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ABSTRACT
Bioactive compounds from plant origin have the potential to subside the biochemical 
imbalances induced by various toxins associated with mutagenesis and carcinogensis. 
Therefore new strategy are interested in finding a potent phytotherapeutic agent with 
non toxic properties. The goal o f the present study to evaluate the potential of Doash- 
leaves water extracts Origanum majorana (2% w/v) as antimutagenic and 
anticarcinogenic effects against known mutagens classes (heterocyclic amines, 
polycyclic aromatic hydrocarbons, nitrosoamines and direct acting carcinogens) in vivo 
and in vitro. The antimutagenic activity was determined by Ames test using different 
strains of Salmonella Typhimurium. Results obtained showed that, Doash extract 
possesses powerful antimutagenic against different mutagene. In vivo study revealed 
that treatment of rats with Doash extracts for one day or 30 days caused a decrease in 
hepatic cytochrome P450 enzymes such as CYP2B, CYP2E1 and CYPIA, the latter 
P450 subfamily being closely associated with the inhibition of chemical carcinogens 
inactivation. Aqueous Doash tea extract diminishes the excretion of indirect acting 
mutagens in rats treated with ( 2-Amino-3-methylimidiazol-[4,50-f]quinoline) IQ or (2- 
hydroxyamino-3-methyl-3H-imidazo[4,5,f] quinoline )PhIP; the antimutagenic effect 
associated with elevation of hepatic CYP1A2 expression which is involved in the 
metabolism of carcinogens ( IQ and PhIP). HPLC/MS analysis o f Doash extract showed 
that a highest peak related to high terpens contents. Based on these records, it appears 
that Doash tea extract can in vivo affect the mutagenicity of various structurally 
diverse promutagens including many food-home carcinogen, by decreasing cytochrome 
P450-mediated activation. It was concluded that, daily intake o f Doash tea may protect
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against the conversion o f promutagene to mutagene and scavenging carcinogen from 
environmental contact. More study is needed to examine the mechanistic action of 
active ingredients of Doash extract fractions on cellular and molecular lev e l.
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Chapter 1
General Introduction
1.1 Natural products
The new attractions of drug discovery using natural products remain an important 
issue in the current herbal medicine research. According to the World Health Organization 
(WHO), about three-quarters of the world’s population rely upon traditional remedies 
(mainly herbs) for their health care (WHO, 1991). The flora of Saudi Arabia is one of the 
richest biodiversity areas in the Arabian Peninsula and comprises very important genetic 
resources of crop and medicinal plants. In addition to its large number of endemic species, 
the components of the flora are the admixture of the elements of Asia, Africa and the 
Mediterranean region. The usage of herbs and medicinal plants of Saudi Arabia for the 
cure of many ailments is ancient and still available among tribal, local people and 
medicinal healers. It is therefore important to develop a better understanding of their mode 
of biological action for new applications in human health, agriculture and the environment.
Origanum majorana L. (maijoram) is an herbaceous and perennial plant, native to 
southern Europe and the Mediterraneam. For food uses, marjoram is employed to flavour 
sausages, meats, salads and soups (Novak et al, 2000). Traditionally, it is used as a folk 
remedy against asthma, indigestion, headache and rheumatism. However, little is known 
about the biologically active compounds of maijoram as a medicinal plant, except for its 
essential oil (Jun et al, 2001). The local Arabic name of Origanum majorana L. is 
‘Doash’ or ‘Bardakush’, and is cultivated in and around the Western region of Saudi 
Arabia, (particularly around the Al-Madina area), for its minty flavour and promotion of 
health. It has been claimed that Doash possesses antispasmodic, carminative, diaphoretic 
and diuretic properties, (Atiqur-Rahman et a l, 2003). It is also used in the treatment of
asthma, coughs and indigestion (Mossa, 2000). This herb is prepared as tea, by infusion in 
hot water, and either used alone or mixed with black tea to enhance its flavour. The present 
study was designed to explore the antigenotoxic effect of the extract of O. majorana.
Carcinogens in foods 1.2
Human carcinogens are often encountered through lifestyle and diet. It is well known 
that dietary factors play a crucial role in the aetiology of human cancer. Cooking food will 
release hundreds of different mutagenic substances. The more protein food contains, the 
more mutagenic material is generated due to cooking. Medical evidence of tobacco smoke 
has been accumulating for 200 years. Tobacco smoke can cause cancers of the lung, 
bladder, head and neck (Peto et al, 2000). Evidence suggests that one third of more than 
500,000 cancer deaths that occur in the United States each year can be attributed to diet and 
exercise, with another third due to cigarette smoking. Although genetic inheritance 
influences the risk of cancer, and cancer arises from genetic mutations in cells, most of the 
variation in cancer risk across populations and among individuals is due to factors that are 
not inherited (Byers et al, 2002).
Although most chemical carcinogens do not react readily with nucleophilic 
macromolecules, they are activated to carcinogenic and mutagenic electrophiles, by 
metabolic processes evolutionarily designed to clear the body from toxins and to modify 
endogenous compounds. Electrophilic chemical species are naturally attracted to 
nucleophiles like DNA and protein. At this stage, the process of carcinogenesis that entails 
irreversible DNA damage (genotoxicity), is referred to as “initiation”. It is followed by the 
more complex and poorly understood long-term stages of promotion and progression.
which lead to the appearance of a tumour. The reactive intermediates may also interact 
with cellular proteins, leading to cytotoxicity, by disturbing physiological homeostasis. 
They may also function as haptens, conferring to the proteins antigenic properties 
(neoantigens), eliciting immunotoxicity, as illustrated in (Figure 1.1). An additional, 
possible interaction of the reactive intermediates is with molecular oxygen, to form 
superoxide anions. These may be found in the presence of traces of iron salts, and can be 
converted to deleterious reactive oxygen species, such as the highly reactive hydroxyl 
radical (OH ), which is a powerful oxidant. These reactive oxygen species cause cellular 
damage, similar to that resulting from the covalent binding of electrophiles to cellular 
constituents. They react covalently with DNA, oxidise lipids to form lipid peroxides, 
which may also facilitate the promotion/progression stages of carcinogenesis. Upon 
internalisation, carcinogens are subject to competing processes of metabolic activation and 
detoxication. There is considerable variation among the human population in these 
competing metabolic processes, as well as the capacity for repair of DNA damage and 
cellular growth control. This is the basis for individual variation in cancer risk, and is a 
reflection of gene-environment interactions, which embodies the concept that heritable 
traits modify the effects of chemical carcinogen exposure (Shields and Harris, 2000). Such 
variations in constitutive metabolism and DNA repair, contribute to the varying reactions 
on exposure to chemicals, and consequently, the relative susceptibility of some individual 
members of the population to chemical exposures.
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Carcinogens 1.3
One of the first chemically identified carcinogens were the polycyclic aromatic 
hydrocarbons (PAH) (Phillips, 1983). They are composed of variable numbers of fused 
benzene rings and are generated as the result of the incomplete combustion of fossil fuels
and vegetable matter, (including tobacco), and which are common environmental 
contaminants. They are chemically inert, and require metabolism to exert their biological 
effects (Guengerich, 2000). This is a multi-step process that involves the following: Initial 
epoxidation ( catalyzed by cytochrome P450, CYPlAl, an inducible isoform), hydration of 
the epoxide, (epoxide hydrolase), and subsequent epoxidation across the oleflnic bond 
(CYPlAl; CYPIBI; CYP3A4) (Figure 1.2). The result is the ultimate carcinogenic 
metabolite, a diolepoxide (Sims et al, 1974; Cooper and Grover, 1983).
Figure 1.2. Metabolic activation of benzol[a]pyrene. (1) Cytochrome P450 (CYPlAl) 
catalyses the initial epoxidation across the 1-2, 2-3, 4-5, 7-8 (shown), 9- 10 and 11-12 
positions. (2) With the exception of the 1-2 and 2-3 oxides that convert to phenols, epoxide 
hydrolase may catalyze the formation of dihydrodiols. (3) Benzo[a]pyrene-7, 8-dihydrodiol 
is further metabolized at the olefinic double bond by cytochrome P450 (CYPlAl, CYPIBI 
and CYP3A4) to form a vicinal diol-epoxide (r7, t8-dihydroxy-c9, 10 epoxy-7, 8, 9, 10- 
tetrahydroxybenzo[a]pyrene). (4) The highly unstable arene ring opens spontaneously to 
form a carbocation. (5) This electrophilic species forms a covalent bond between the 10 
position of the hydrocarbon and the exocyclic amino group of deoxyguanosine (From Kufe 
et aï., 2003).
The arene ring of benzo[a]pyrene-7, 8-diol 9, 10-oxide opens spontaneously at the 10 
position, giving a highly reactive carbonium ion, which can then form a covalent addition 
product (ie, adduct), with cellular macromolecules, including DNA. An alternative 
pathway of PAH activation, through a mechanism of one electron oxidation, has also been
postulated (Stack et al, 1995). When benzo[a]pyrene is activated by this route, the 
resulting radical action is formed at the meso position or L-region (Cooper, et al, 1983). 
The reactive oxygen species forms DNA adducts at the C8 of guanine (BP-6-C8Gua and 
BP-6-C8dGua), the N7 of guanine (BP-6-N7Gua), and the N7 of adenine (BP-6-N7ade) 
(Figure 1.3). These adducts place a strain on the A-glycosyl link to the helical backbone 
and the result is depurination. Firm evidence for the exfoliation of these adducts in urine 
was recently provided for in exposure scenarios that included coal and tobacco smoke 
(Casale et al, 2001).
The heterocyclic amines form while cooking food, primarily from the pyrolysis 
(>150°C [302°F]) of amino acids, creatinine, and glucose. They have been recognised as 
food mutagens (Felton et al, 1997), shown to form DNA adducts and cause liver tumours 
in primates (Adamson, 1989). These compounds are activated by CYP1A2, and their 
metabolites form DNA adducts in humans (Gamer et al, 1999). The 7V-hydroxy 
metabolites of 3 -amino-1 -methyl-577- pyrido [4,3 -b] indole (Trp-P-1), 2-amino-6- 
methyldipyrido[l,2-a:39,29-d]imidazole (Glu-P-1), and 2-amino-3-methyl-imidazo- [4,5- 
f]quinoline (IQ), can react directly with DNA. Enzymic O-esterification of 7V-hydroxy 
metabolites play a key role in activating food mutagens, and the iV-hydroxy metabolites are 
also good substrates for transacetylase. This suggests a possible aetiologic role for these 
chemicals in colorectal cancer, with the rapid acetylator phenotype (Neville et al .,2000).
d-Ribose
c
m.
d-Kbose
T
d-Kbose
Figure 1.3. Examples of carcinogen-DNA adducts: (A), N7(benzo[a]pyren-6-yl)guanine; 
(B), 7V-(deoxyguanosin-8-yl)-{acetyl} aminobiphenyl (when R= H the adduct is not 
acetylated [R can also be an acetyl group]); (C), 8,9-dihydro-8-(N^-formyl- 2% 5% 6'- 
triamino-4'-oxo-N^-pyrimidyl)-9-hydroxy-aflatoxinBi; (D), 0^-[4- Oxo -4 (3-pyridylbutylj 
guanine, a mutagenic lesion formed by the metabolism of the tobacco-specific nitrosamine, 
NNK; (E), N7-methyldeoxyguanosine; and (F), 3-methyladenosine. Adducts E, and F, can 
also result as the small alkyl products of NNK metabolism. (From Kufe et al, 2003).
N-Nitrosamines are a large group of potent carcinogens. Approximately 300 different N- 
nitrosamines are carcinogenic (Smyk et al., 1990). There is little doubt that humans 
exposed to sufficient amounts of N-nitrosamines would also be susceptible to their 
carcinogenic effects. Human exposure to pre-formed N-nitrosamines occurs through the 
diet, in certain occupational settings, and through the use of tobacco products, cosmetics, 
pharmaceutical products, and agricultural chemicals. Diminishing human exposure to these 
carcinogens is one approach to prevention of cancer, and this has been accomplished in 
many instances, although exposure to N-nitrosamines in tobacco products is still
unacceptably high. Human exposure to N-nitrosamines also occurs by nitrosation of amines 
in the body, via their acid or bacterial catalysed reaction with nitrite, or by reaction with 
products of nitric oxide, generated during inflammation or infection ( Ryzard,2003). A 
second approach toward prevention of N-nitrosamine carcinogenesis is inhibition of this 
endogenous N-nitrosamine formation. Substantial reductions have been achieved with 
ascorbic acid and other nitrite scavengers. The third approach involves the use of 
chemopreventive agents that block this step, or other steps in the carcinogenic process. A 
large number of potent chemopreventive agents against nitrosamine carcinogenesis have 
been identified. Chemoprevention of lung cancer induced by the tobacco-specific 
nitrosamine 4-(methylnitrosamino)-1 -(3-pyridyl)-1 -butanone (NNK) is discussed as an 
example of this approach (Hecht, 1997).
Epidemiological evidence 1.4
It is widely accepted that the manipulation of diet to increase the intake of 
anticarcinogens in fresh fruits and vegetables is the best recommendation offered today to 
reduce cancer risk (Bailey and Williams, 1993; Abdulla and Gruber, 2000). Fruits and 
vegetables contain natural inhibitors of mutagenesis and carcinogenesis which act as 
“chemoprotective interventor agents” (Hammons et a l, 1999). These agents are 
phytochemicals present mainly in fruits and vegetables (Oomah and Mazza, 2000; Abdulla 
and Graber, 2000). Identification of the nature of these dietary constituents has been on the 
rise in the last few years. A list of some identified chemoprotective agents (called also 
mutagen and carcinogen modulators) has been presented recently, and includes more than
150 natural phytochemicals, micronutrients and antioxidants, as well as a large group of 
polyphenols, flavones, retinoids and porphyrins (reviewed by Dashwood, 2002). An 
additional list of possible antimutagenic natural substances, comprising 26 vitamins and 
related compounds, has been also reported (Edenharder et ah, 1999).
Epidemiological studies have shown that regular consumption of fruits and vegetables was 
related to reduced risk of chronic diseases, such as cancer and coronary heart disease. It 
has shown that fruits and vegetable extracts exhibit strong antioxidant and antiproliferative 
activities and that the major part of total antioxidant activity is from the combination of 
phytochemicals. The phytochemicals in fruits and vegetables are responsible for these 
potent antioxidant and anticancer activities and that the benefit of a diet rich in fruits and 
vegetables is attributed to the complex mixture of phytochemicals present in whole foods 
(Rui,2004).
Major types of macronutrients, including amino acids such as glutamine, lipids such as the 
omega-3 polyunsaturated fatty acids, vitamins such as C and E are commonly used as 
antioxidants, while zinc and selenium are minerals with a wide spectrum of impacts on the 
immune system. Some of the most potent immunomodulators are phytochemicals such as 
the polyphenols, or curcumin, or isothiocyanates (Ferguson and Philpott .20071.
It is of critical importance to understand the modulation of mutagenic and 
carcinogenic effects, which are induced by potential chemical mutagens and carcinogens,
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in order to evaluate the final outcome of chemical exposure to these noxious substances. 
Consequently, it is important to understand how promoters and inhibitors of mutagenesis 
and carcinogenesis work at the molecular level.
Chemopreventive phytochemicals 1.5
The most thoroughly investigated dietary components in fiuits and vegetables, acting as 
antimutagenic, anticarcinogenic and antioxidant agents, are polyphenols. An example of 
these is epigallocatechin gallate (EGCG), which is present in substantial amounts in green 
tea leaves (Kuroka and Hara, 1999; Karakaya and Kavas, 1999). These compounds may act 
independently, or in combination, as anti-cancer agents by a variety of mechanisms, such 
as fi*ee radical scavenging, metal chelation, or as a enzyme activity modulators.
Polyphenols are one of the most important classes of natural antioxidants present in 
fiuits and vegetables that have been shown to play a crucial role in the prevention of 
various diseases. One of the most famous, natural products rich in polyphenols is tea. These 
compounds are secondary plant metabolites and confer on fruits and vegetables both 
desirable and undesirable, food qualities. Historically, they were considered as anti­
nutrients because some, (such as tannins), were shown to have adverse affects on human 
metabolism ( Bahatta et al., 2000). However, the recognition of antioxidative properties of 
these phenolics has evoked a re-thinking towards their health benefits (Bravo, 1998). 
Polyphenols account for the majority of antioxidant activity when compared with vitamin E
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(a- tocopherol) and vitamin C (L-ascorbic acid) (Nishina et a l, 1991; Wang et a l, 1996; 
Deighton et a l, 2000). A number of epidemiological studies, linking lower rates of cancer 
incedence with the consumption of green tea, have emerged (Kuroda and Hara, 1999). In a 
case-controlled study in urban Shanghai, People’s Republic of China, it was shown, for 
example, that consumption of green tea, rich in polyphenols, reduced the risk of human 
oesophageal cancer, suggesting a protective role of green tea against cancer (Gao et al, 
1994).
(.Doash (origanum majorana L 1.6
Since human cancer incidence is linked to dietary habits and lifestyle, as clearly 
indicated by mounting evidence, some of which was discussed in various sections of this 
survey, it is of great interest to search for a simple diet, a common beverage or an herbal 
remedy, to provide means of protection against cancer. Medicinal plants in Saudi Arabia 
constitute around 12% of the total number of its floral species (Atiqur et al., 2003), the total 
number of endogenous species being 2,300. Among them 300 species, belonging to 72 
families, are considered as medicinal plants. The Labiatae, or the mint family, (recently 
named Lamiaceae) has 76 species, of which 22 are considered to be medicinal plants. One 
of these plants is Origanum majorana L. which in Arabic, is called Doash, Bardakush or 
Za’ater, and sweet marjoram or maijoram as common names (Figures 1.4, 1.5). The wild 
marjoram (Origanum vulgare) is another name for the famous herb, oregano.
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Doash or maijoram is an herbaceous and perennial plant, native to southern Europe and 
the Mediterranean. It is cultivated for food use and is employed as a flavour. Traditionally, 
it is used as an antispasmodic, carminative, diaphoretic folk remedy, together with a 
diuretic natural medication. It is also used in the treatment of asthma, cough, indigestion 
and headache (Mossa et al, 2000).
Although green tea is heavily consumed in Saudi Arabia, another herbal drink Doash, of 
endogenous nature, is also consumed by many people. This herbal drink is made by the 
infusion of fresh leaves of Doash in hot water, and is consumed either alone as a sole drink, 
or after being added to black or green tea as a flavour. This local herb, along with other 
mint species, is widely cultivated in many parts of Saudi Arabia, especially around the holy 
city of Madinah, where the grave of Prophet Mohammad - Peace Upon Him -  has been 
held for almost 1,400 years.
The leaves of Origanum majorana L. contain 0.29% of its weight as volatile oils (Table 
1.1). They are mainly terpenoids, such as nor-bomeol, cineole, linalool, menthol, citral, 
citronellal, in addition to at least seven other unidentified volatiles (Gasim and El-Sharief 
1994). A more recent analysis of maijoram oil, using a GC-MS method, indicated the 
presence of 42.1% hydrocarbons, 24.3% alcohols and 14.2% phenols in the essential oil 
(Daferera et a l, 2000). Another study on the chemistry of the essential oil of O. majorana 
was conducted using GC-MS analysis, and showed several additional compounds. Among 
them are sabinene (5.2%), p-cymene (11.3%), limonene (1.6%), a-terpinene (1.6%), trans- 
sabinene hydrate (5.8%), terpinen-4-ol (27.5%), a-terpineol (4.8%), cfr-sabinene hydrate 
acetate (10.2%), linyl acetate (7.4%) and caryophyllene oxide (1.7%). Some of these 
compounds acted as insect (thrips) antifeedants (Koschier et a l, 2002). The essential oil
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obtained by steam distillation contains mainly terpinen-4-ol (>20%) which, with cis- 
sabinene hydrate (3-19%), is responsible for the characteristic flavour and aroma of 
maijoram oil (Vagi et a l, 2004). In addition to these compounds identified in the essential 
oil of marjoram, appreciable amounts of a-pinene, a-myrcene, p-cymol and several other 
terpenoids have been determined (Vagi et a l, 2004). Marjoram essential oil also contains a 
significant amount of a phenolic substance called carvacrol (2-methyl-5-( 1 -methylethyl) 
phenol) which showed weak activity in mutagenicity tests (De Vincenzi et a l, 2004). It 
increases the histidine revertant numbers in the Ames tests strain TA 100, regardless of 
metabolic activation, but not to a significant level. Some terpenoids present in the volatile 
and essential oil fractions of Doash leaves, such as eugenol, cineole, terpinen-4-ol and 
thymol, are known to possess antioxidant activity (Lee et al, 2004).
A recent study was conducted using several species of herbs belonging to the genus 
Origanum, to determine their antioxidant properties by using six in vitro assays (Dorman et 
a l, 2004). The water-soluble extracts of the different Origanum species showed variable 
degrees of activity, depending upon the amount of polar phenolic compounds present in 
each extract. In addition, a methanol extract of maijoram leaves exhibited strong 
antioxidant activity by scavenging superoxide (O2 ) free radicals (Jun et a l, 2001). The 
scavenging activity was found to be associated with phenolic compounds, as well as caffeic 
acid derivatives and flavonoids. Maijoram was also used effectively in a mixture with 
other spices to retard the oxidative spoilage of minced meat-balls (Karpinska et al, 2001). 
It was also used to improve the quality of bakery products due to its antioxidant activity 
(Bassiouny et a l, 1990).
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Ursolic acid (3 beta-Hydroxyurs-12-en-28-oic acid) has been isolated also from the 
Doash leaves and was found to prevent the formation of reactive oxygen species (ROS) and 
prevent lipid peroxidation in PC12 nerve cells subjected to Abeta (Amyloid beta protein), 
which causes oxidative injury (Heo et a l, 2002). Moreover, ursolic acid possesses potent 
anti-acetylcholinesterase (AchE) activity that may be useful in the treatment of Alzheimer’s 
disease (Chung et al, 2001). The inhibition of AchE enhances cholinergic transmission by 
reducing the enzymatic degradation of acetylcholine (Ach). Among 139 herbal species 
tested for anti-AchE activity, the ethanol extract of O. majorana L. was the most active 
AchE inhibitor. On sequential fractionation of the ethanolic extract, the active component 
was identified as ursolic acid, which had an IC50 value (the concentration required for 50% 
of enzyme inhibition) of 7.5nM (Chung et a l, 2001). Maijoram, and other commercially 
available flavours or spices, were tested against the formation of Phi? (2-amino-1-methyl- 
6-phenylimidazol [4,5-bjpyridine) during cooking in a model system (Zochling et al, 
2002). PhIP is a heterocyclic aromatic amine, belonging to a class of mutagens found in 
food, particularly in grilled or fried fish and meat products. It was shown that maijoram, 
and other tested spices, possessed antioxidant properties and influenced the production of 
PhIP in the model system. The oregano, another related species {Origanum vulgare), 
possesses antioxidative properties, such as preventing lipid peroxidation (Botsoglou et al, 
2004).
Table 1.1 Some chemical constituents of Doash leaves (From Gasim and
El Sharief, 1994).
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Volatile oil 
(0.29 % w/w)
nor-borneol, cineole, linalool, menthol, 
c itra l, citronellal 
plus at least seven other unidentified) 
(volatiles
Elements w/w %
Nitrogen 0.106 ±1.134
Calcium 0.032 ± 0.200
Potassium 0.092 ± 0.757
Phosphorous 0.007 ± 0.086
Magnesium 0.007 ± 0.086
Sodium 0.005 ±0.015
ppm
Iron 14.9 ±116.3
Manganese 1.48 ±23.03
Zinc 0.357 ±3.41
Copper 0.357 ±3.41
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At least six flavonoids (6-hydroxy flavonoids) have been identified in the methanolie 
extract O. majorana leaves. Some of these flavonoids are potent inhibitors of alpha-rat 
intestinal glucosidase activity at a concentration range from 12 to >500pM (Kawabata et 
al, 2003). In addition, Leeja and Thoppil (2007) found that a methanol extract of
O.major ana can be used as an effective herbal protectant against different pathogenic 
bacteria and fungi. Moreover, some compounds present in the essential oil fraction of 
maijoram, possess potent antimicrobial activity against various bacterial and fungal species 
(Vagi et a l, 2004). Recently, Razieh and Leila, (2008) found that Origanum majorana 
inhibited the blood platelet adhesion in the vessel wall, which is an important factor 
responsible for thrombosis and the incidence of cardiovascular disease.
The presence of these various, bioactive compounds present in Doash leaves could 
play a role in the proposed antimutagenic and anticarcinogenici activities of this herbal 
plant. Therefore, the aims of our proposed research study are:
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Figure 1.4: Origanum majorana L.
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Figurel.5: Doash (origanum majorana L.)
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Herbs and spices have been traditionally used for their flavor-enhancement characteristics 
and for their medicinal application. Herbs and spices are minor dietary constituents with 
multiple anticancer , anti-microbial, antioxidant, and anti-tumorigenic properties .Their 
ability to influence carcinogen bioactivation(Christine and John ,2008).
Aims of the project 1.7
1. To evaluate the antimutagenic potential of the water-extracts of Doash-leaves against 
several known mutagens, both direct and indirect-acting, belonging to different chemical 
classe ofheterocyclic amines, polycyclic aromatic hydrocarbons and nitrosamines. The 
antimutagenic activity will be determined in the Salmonella/microsomal system (Ames), 
using strains of Salmonella Typhimurium.
2. To explore the possible underlying mechanism for the antimutagenic activity of Doash 
extracts, by investigating its ability to modulate cytochrome P450 enzymes involved in the 
bioactivation of chemical carcinogens. Furthermore, the potential of Doash to scavenge the 
reactive intermediates of carcinogens, that might be produced during the biotransformation 
of mutagens and carcinogens, will be evaluated.
3. To separate aqueous Doash extracts to a number of fractions and assess their 
antimutagenic activity, so as to identify the responsible components.
4. To investigate whether long-term administration of aqueous Doash extracts modulates 
the hepatic levels of the xenobiotic-metabolising cytochrome P450, and phase II enzymes.
2 0
5. To determine the potential of aqueous extracts of Doash to modify the metabolism of 
heterocyclic amines in rats, as exemplified by the excretion of mutagens in urine.
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Chapter 2
Materials and Methods
2 2
Materials 2.1 
2.1.1Chemicals
9-Aminoacridine, ampicillin, benzo[a]pyrene, crystal violet, 7,12- 
dimethylbenz [a] anthracene, Folin Ciocalteau’s reagent, MNNG, menadione, 4- 
nitrocatechol, N-nitrosopiperidine, N-nitrosopyrrolidine, potassium sodium tartrate, acetic 
acid glacial, bovine serum albumin, citric acid, copper sulphate, formaldehyde, glucose, 
magnesium chloride, magnesium sulphate, perchloric acid, potassium phosphate, sodium 
carbonate, glucose-6-phosphate, NADP, NADPH, ethoxyresorufin, methoxyresorufin, 
pentoxyreserorufin, resorufin, number 2 nutrient broth, Lab. M No. 1 agar, L-histidine, 
ascorbic acid, L-glutathione, gallic acid, sodium dodecanoate, menadione sodium 
bisulphate, glucose-6-phosphate dehydrogenase, 3,4-dichloronitrobenzene (DCNB), 1- 
chloro-2,4-dinitrobenzene (CDNB), reduced glutathione, 2-naphthol, 2-mercaptoethanol, 
adenosine 3 '-phosphate 5 '-phosphosulphate (PAPS), Triton X-100, UDP-glucuronic acid, 
benzo(a)pyrene-4,5-epoxide, benzo[a]pyrene-4,5-dihydrodiol, erythromycin. Tris HCL, 
N,N,N',N'-tetramethylenediamine (TEMED), acrylamide, bis-acrylamide, glycerol, p- 
mercaptoethanol. Tween 20, and methanol were purchased from Sigma-Aldrich Inc., USA. 
2-Amino-3-methylimidazol-[4,5-f]quinoline(IQ), 2-Amino-1 -methyl-6-phenylimidazo[4,5- 
6]pyridine (PhIP), and V-OH-2-amino-3-methylimidazo[4,5-/| quinoline were supplied by 
Toronto Research Chemicals, Toronto, Canada. NADP/G-6-P tablets were supplied by 
Roche Company, NJ, USA. Mini Trans-Blot electrophoretic Transfer cell and
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nitrocellulose membrane (0.2 jim) were purchased from Bio-Rad Laboratories, Hercules, 
California 94547, USA.
2.1.2 Reagents
Primary and secondary antibodies CYP2B1, CY2B2, CYP2E1, CYPlAl, CYP1A2 and 
CYP3A2 were purchased from Abeam pic. Primary antibodies were: ab78179 rabbit 
polyclonal against cytochrome P450 lA l, ab22717 mouse monoclonal [dl5 (16VII 
F10F12)] against cytochrome P450 1A2, ab22719 mouse monoclonal [b/e3 (9.14)] against 
cytochrome P450 2B1+2B2, abl9140 rabbit polyclonal against cytochrome P450 2E1, and 
ab22724 mouse monoclonal [P6] against cytochrome 3A1.
Secondary antibodies (all polyclonal) were: goat anti-rabbit IGg-H&L, rabbit anti-mouse 
IgG-H&L, and rabbit anti-sheep IgG-H&L.
The Salmonella typhimurium strains were generous gifts from Professor C. Ioannides,_- 
University of Surrey, Guildford, Surrey, UK.
Hepatic S9 preparations from Aroclor 1254-treated rats and isoniazid-treated rats were 
obtained from the University of Surrey, Guildford, Surrey, UK.
24
Methods 2.2 
Animals 2.2.1
Male Wistar albino rats (WA) were purchased from the animal house in King Fahad 
Medical Research Center KAU, Jeddah. They were kept in metabolic cages in a controlled 
room temperature at 22 ± 1 °C and 50% humidity. Light/dark cycles were set at 12 hrs. 
Animals were given free access to water and standard rodent diet during the experimental 
periods.
Preparation of Doash extract 2.2.2
Doash plant was purchased locally. Doash tea (2 g) was infused in a thermos flask with 
100 ml boiled distilled water. The flask was shaken every minute for a duration of 10 
minutes to obtain an approximately 2% (Doash:water) Doash tea extract. Fresh extracts of 
Doash tea extract were prepared and used.
Preparation of hepatic subcellular fractions 2.2.3
The preparation of whole liver homogenate and other subcellular fractions was performed 
according to the method of loannides and Parke (1975). All steps were carried out at 0-4 
°C using cold sterile solutions and equipment. Animals were sacrificed by cervical 
dislocation and the whole livers immediately excised and placed in tubes immersed in ice.
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The tissues were then rinsed in 1.15 % (w/v) KCL to remove excess blood and blotted dry 
before weighing. Livers were manually scissor-minced and then homogenized using a 
Potter Elvehjem homogeniser (glass vessel and Teflon plunger). The homogenate was 
adjusted to a 25% (w/v) suspension with ice-cold 1.15% (w/v) KCL The liver homogenate 
was centrifuged at 9000g for 20 min at 4°C using a J2-21 centrifuge equipped with a JA-17 
rotor, to remove debris, nuclei, mitochondria and lysosomes. The supernatant (S9, 
microsomal supernatant) was decanted into LP3 plastic tubes (3 ml) and stored at -20°C 
until use. For the preparation of microsomal and cytosolic fractions, S9 samples were 
defrosted on ice and transferred to polyethylene centrifuge tubes and centrifuged at 45,000 
rpm (105,000 g) for 60 min at 4 °C using a Beckman L7-65 ultracentrifuge equipped with a 
Ti-70 type rotor. The supernatant, cytosolic fraction was decanted and the remaining pellet 
was re-suspended in the original volume, of 1.15% (w/v) KCI using a Potter Elvehjem
homogeniser as described previously. The re-suspended pellet is termed the microsomal 
fraction. The microsomal and cytosolic fractions were freshly prepared as required and 
used immediately.
The Ames Salmonella mutagenicity test 2.2.4
The test described by Maron and Ames (1983) was used to investigate the mutagenic 
anti-mutagenic potential of xenobiotics.
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Characteristics of the bacterial tester strains 2.2.4.1
Four Sallmonelia bacterial strains (TA98, TA97, TAIOO and TA1530) were used in the 
present study. These strains contain different mutations in the histidine operon allowing 
the bacteria to detect different types of mutation. The two strains (TA98 and TA97) are 
capable of detecting frame-shift mutations, while TAIOO and TA1530 are able to detect 
base-pair substitutions. Moreover, the tester strains contain other mutations that greatly 
increase their sensitivity to the various mutagens. The rfa mutation leads to partial loss of 
the lipopolysaccharide barrier that coats the surface of the bacteria. This enhances entry of 
benzo[a]pyrene, that would otherwise not readily penetrate the normal bacterial cell wall. 
Deletion of the uvrB gene increases the sensitivity of the tester strains to detect many 
mutagens. TA98, TA97 and TAIOO strains contain also the R-factor plasmid (FkmlOl), 
which renders the bacteria more sensitive to reversion by mutagens that are weakly 
detected, or not at all, by the parent strains lacking the R-factor plasmid (McCann et al. 
1975b; Levin et al. 1982a). The plasmid pKMlOl stimulates an error-prone DNA repair 
system, normally present in these organisms, resulting in enhanced chemical and 
spontaneous mutagenesis (McCann et al. 1975b).
2.2.4.2 DNA sequence specificity of the bacterial tester strains
The mutation of TAIOO and TA1530 in the hisG gene, which codes for the first enzyme 
involved in histidine biosynthesis (Ames 1971), substitutes one of the three G-C base-pairs
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of proline for an A-T base pair, giving leucine (Leu) in the wild-type organism. TAIOO 
and TA1530, can therefore detect chemicals that cause base-pair substitutions at one of 
these G-C base-pairs. TA98 has the hisD3052 gene, which has 8 repetitive G-C residues, 
and which codes for histidinol dehydrogenase. Therefore, reversion is due to frame shift 
mutagens. TA97 has mutations in hisD6610 gene, which codes for the first enzyme 
involved in histidine biosynthesis.
Storage of the bacterial tester strains 2.2.4.3
The frozen stocks of Salmonella tester strains were made from fresh overnight cultures. 
Pure grade DMSO was added (0.9% v/v), mixed, distributed into sterilized ciytubes and 
stored at -80°C.
Culturing of bacterial tester strains 2.2.4.4
Cultures of bacterial tester strain TA1530 were grown in fresh Oxoid nutrient broth (25 
mg/ml) and fresh Oxoid nutrient broth (25 mg/ml) containing ampicillin (25 mg/ml) for 
strains TA97, TA98 and TAIOO. 10 mis of sterile nutrient broth was inoculated with 
frozen bacterial stocks using a standard, sterile platinum loop. The inoculated nutrient broth 
.was then incubated for 12 hrs at 37°C in a shaking water bath
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Bacterial tests 2.2.4.S
In order to ensure that the bacterial strains still retained their mutations, the genotypes of 
bacterial strains used in Ames test were checked. All tests were carried out in triplicate and 
confirmation was achieved as follows:
1. Histidine requirement
Removal of the uvrB gene causes partial loss of the bio gene, so J-biotin as well as L- 
histidine must be present to obtain growth of the tester strains. To demonstrate histidine 
requirement of the bacterial tester strains, a volume of 100 pi of a high histidine/biotin 
solution (0.1 M L-histidine and 0.5 mM biotin) was spread on the surface of a minimal 
histidine plate (Maron and Ames 1983). The same volume of buffer containing 0.5 mM 
biotin, but no histidine, was spread on an identical plate. After the plates had dried, fresh 
bacterial cultures were streaked onto the plates and then incubated for 24 hrs at 37°C. 
Growth on plates with histidine/biotin supplementation only, demonstrated retention of the 
histidine mutation.
2. rfa mutation
Detection of the rfa mutation was performed by sensitivity to crystal violet. Fresh 
bacterial culture (100 pi) was added to 2 ml of nutrient agar (0.6% [w/v], NaCl: 
0.5% [w/v] containing 100 pi of high histidine/biotin, (0.1 M histidine, 0.5 mM 
biotin). The mixture was vortexed and poured onto a minimal histidine plate and 
allowed to set. A sterile filter disc (1 cm diameter) was placed on the agar in the
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centre of the plate, and 50 pi of a crystal violet solution (1 mg/ml) was pipetted onto 
the filter disc, and the plate incubated for 24 hr at 37°C. An inhibition zone 
appearing around the disc indicates presence of the rfa mutation, (Figure 2.1)
Figure 2.1 Ames Test: Detection of rfa mutation by Crystal Violet.
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3. Detection of the pKMlOl plasmid
The plasmid pKMlOl increases the resistance of Escherichia coli and Salmonella 
typhimurium to the lethal effects of UV radiation and also increases the susceptibility of 
cells to mutagenesis by UV and a wide variety of chemical agents. The inclusion of 
pKMlOl in the S. typhimurium strains used in the Ames test for mutagens has substantially 
increased the range and sensitivity of this test system (Ames etal., 1975). Since it is 
essential to check the R-factor bacterial tester strains (TA98, TAIOO) for ampicillin 
resistance, minimal glucose plates were prepared and 50 pi of ampicillin (8 mg/ml in 0.02 
M NaOH) was poured onto the filter disc in the middle of the plate, which was incubated 
for 24 hr at 37°C. No inhibition zone around the filter disc indicates presence of the R- 
factor and hence the pKMlOl plasmid.
4. Viability Test
An aliquot of fresh bacterial culture (0.1 ml) was added to 10 ml of sterile nutrient 
broth. This mixture was vortexed and a 100 pi aliquot was removed and added to another 
10 ml of sterile nutrient broth. This procedure was repeated once more and finally 100 pi 
of the last dilution was removed and added to 2 ml of nutrient agar, containing 100 pi of L- 
histidine (0.1 M) and biotin (0.5 mM). This mixture was vortexed and poured onto a 
minimal glucose plate and incubated for 24 hr at 37°C. The number of colonies was 
counted and the bacterial viability (the number of bacteria per ml of original culture) was
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calculated. Viability should be in the region of 1-2 xio^ bacterial cells per ml of fresh 
bacterial culture (Maron & Ames, 1983).
Spontaneous reversion rates. 2.2.4.6
The Spontaneous reversion rate reflects the number of bacterial colonies that revert back 
from His' to His^. The spontaneous reversion rates of Salmonella typhimurium bacterial 
tester strains were tested.
2.2.4.7 The plate incorporation test
In sterile capped plastic culture tubes, 2 ml of nutrient agar (0.6% [w/v] Difco agar, 0.5% 
[w/v] NaCl), containing 200 pi of low histidine/biotin, (0.5 mM histidine, 0.5 mM biotin), 
was maintained at 45°C dry bath, 100 pi fresh bacterial culture, 100 pi putative mutagen, 
100 pi of test compound and 500 ul of S9 activation system were pipetted into the culture 
tubes. The tubes were vortexed and poured onto minimal plates. When the agar had 
solidified, the plates were incubated for 48 hrs at 37°C and the revertant colonies counted 
manually using a Gallenkamp colony counter. Each test was performed in triplicate and 
appropriate positive and negative controls were included (Table 2.3).
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Table 2.1 Positive controls with or without S9 activation system for 
different Salmonella strains.
Bacterial
strain
With S9 activation system Without 89 activation 
system
Mutagen Concentration Mutagen Concentration
TA-98
TA-100
TA1530
TA97
aminoanthracene-2
aminoanthracene-2
aminoanthracene-2
aminoanthracene-2
5pg/ plate 
5pg/ plate 
5|Jg/plate 
5 Mg/ plate
Nitrofluorene-2
MNNG
MNNG
aminoacridine-9
2pg/ plate 
Ipg/ plate 
Ipg/ plate 
pg/ plate 5
The metabolic activation system 2.2.4.S
The metabolic activation system contained 10% of the hepatic fraction (section 2.2.4). 
The activation system was supplemented with glucose-6-phosphate dehydrogenase (1 unit/ 
plate) if the microsomal fraction was used in place of the hepatic 89 fraction. If it was 
necessary to alter the percentage of liver fraction used in the activation system, volume 
adjustment was achieved by altering the amount of phosphate buffer added, so that the total 
volume of the activation system remained constant (Table 2.2).
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Table 2.2 Constituents of the hepatic metabolic activation system
Components of the hepatic metabolic activation system Percent
(Potassium chloride (0.33 M 10%
(Potassium phosphate buffer (0.2 M,pH 7.4 50%
(Magnesium chloride (0.08 M 10%
(Liver fraction (25% w/v 10%
Co-factor solution (20 mmol/ml NADP and 25 mmol/ml 
(glucose-6-phosphate
20%
Determination of protein concentration 2.2.7
The concentration of protein content of tissue was determined according to the method of 
Lowry et al, (1951). It is based on a coloured complex formed from the reaction between 
the alkaline copper-phenol reagent and the tyrosine and tryptophan residues of the protein. 
A standard curve was constructed using a serial (20-250 pg) dilution of bovine serum 
albumin (BSA) (500 pg/ml). Blank, BSA standards and test samples were set up in 
triplicate. To each tube (containing 1 ml of diluted tissue sample,) 5 ml of freshly prepared 
copper reagent (1 volume copper sulphate [1% w/v]: 1 volume sodium potassium tartrate 
[1% w/v]) and 100 volumes sodium carbonate [2% w/v] were added and immediately 
vortexed. Samples were allowed to stand at room temperature for 10 min, and then 0.5 ml
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of freshly diluted Folin Ciocalteau’s reagent (1:1 dilution with water) was added and 
vortexed. Tubes were allowed to stand at room temperature for approximately 30 min and 
absorbance read at 720 nm using an Apel 303 S Japan spectrophotometer. Protein 
concentrations were calculated using the standard curve.
(Assay of phase I enzyme activity (mixed function oxidases 2.2.7.1
Cytochrome P450 isoforms were determined respectively as follows. All assays were 
conducted in duplicate, including appropriate blanks and standards.
2.2.7.1.1 Ethoxyresorufin O-deethylase
The enzyme activity was determined according to the method Burke & Mayer, (1974). It 
is based on the rate of production of resorufin from the dééthylation of ethoxyresorufin and 
measured fluorometrically using a Perkin-Elmer LS5 luminescence spectrophotometer. 
The excitation wavelength was set at 510 nm (slit width 10 nm) and the emission 
wavelength set at 586 nm (slit width 2.5 mm).
The following reagents were mixed in a 3 ml fluorimeter cuvette
Tris-HCI buffer (0.1 M, pH 7.8 at 37 °C) 2 ml
Microsomal fraction (25% w/v) 100 pi
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Ethoxyresorufin (0.5 mM) lOpl
At baseline, the reaction was intiated by addition of 10 pi of NADPH (50 mM in 1% 
NaHCOs) and the reaction was followed for at least 2 minutes. The activity was determined 
from the initial linear rate. Ten pi aliquots of resorufin (0.1 mM) were used as standards.
Methoxyresorufin O-demethylase 2.2.7.1.2
The 0-demethylaion rate of methoxyresorufin to resorufin is catalysed selectively by the 
CYP1A2 protein according to the method of Burke & Mayer, (1974). It is based on the 
production of resorufin from the déméthylation of methoxyresorufin and is measured 
fluorometrically. Fluorescence was measured using a Perkin-Elmer LS5 luminescence 
spectrophotometer. The excitation wavelength was set at 510 nm (slit width 10mm) and 
the emission wavelength set at 586 nm (slit width 2.5 m).
:The following reagents were mixed in a 3 ml fluorimeter cuvette 
Tris-HCI buffer (0.1 M, pH 7.8 at 37 °C) 2 ml
Microsmal fraction (25% w/v) 100 pi
Methoxyresorufin (0.5mM) 10 pi
The reaction was initiated by the addition of 10 pi of NADPH (50 mM inl%  NaHCOs) and 
was followed for at least 2 minutes. The activity was determined from the initial linear rate. 
lOpl aliquots of resorufin (0.1 mM) were used to construct a standard curve.
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Pentoxyresorufin O-depentylase 2.2.7.1.3
Measurement of pentoxyresorufin dealkylation was based on the procedure described by 
Lubet et al, (1985). The reaction is catalysed by the CYP2B enzymes. The formation of 
resorufin firom the depentylation of pentoxyresorufin is measured fluorometrically. 
Fluorescence was measured using a Perkin-Elmer LS5 luminescence spectrophotometer. 
The excitation wavelength was set at 510nm (slit width 10 mm) and the emission 
wavelength set at 586 nm (slit width 2.5 mm).
The following reagents were mixed in a 3ml fluorimeter cuvette:
Tris-HCL buffer (0.1 M, Ph 7.8 at 37 °C) 2ml
Microsomal fraction (25% w/v) 100 pi
Pentoxyresorufin (0.5 mM) 10 pi
At baseline, the reaction was stared by the addition of 10 pi of NADPH (50 mM in 1% 
NaHCOs) and the reaction was followed for at least 2 minutes. The activity was 
determined fi-om the initial linear rate. 10 pi aliquots of resorufin (0.1 mM) were used to 
construct a standard curve.
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Erythromycin N-demethylase 2.2.7.1.4
Formaldehyde produced from the N-demethylation of erythromycin was determined 
colourimetrically. This reaction is catalysed by the CYP3A subfamily according to the 
method of Wrighton et al, (1985).
The incubation mixture was prepared in LP3 tubes and comprised:
Potassium phosphate buffer (0.05 M, pH7.25) 390 pi
MgCh (0.15M) 100 pi
Erythromycin (0.01 M) (dissolved in minimal amount of 0.5
M HCl, and then made up to the appropriate volume with water) 100 pi
NADP (12.5 mM) 100 pi
Glucose-6-phosphate (G-6-P) (0.15 M) 100 pi
Microsomal fraction (25% w/v) 200 pi
The reaction was started by addition of 10 pi (2 units) G-6-P dehydrogenase then incubated 
for 10 min 37 °C and the reaction was stopped by addition of 0.5 ml ice-cold trichloroacetic 
acid (12.5% w/v). Samples were centrifuged for 10 min at 2500 rpm using a Beckman J-6 
centrifuge. A 1.0 ml aliquot of the supernatant was added to 1.0 ml of freshly prepared 
Nash regent (4 M ammonium acetate containing 4 pl/ml acetylacetone), mixed and 
incubated for 40 min at 37 °C in a shaking water bath. Tubes were allowed to cool to room 
temperature and the absorbance was read at 412 nm using an Apel 303 S Japan 
spectrophotometer. Standards (0-0.5 pmol formaldehyde) and blank were prepared in the
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same manner, except that the erythromycin was added after termination of the reaction with 
0.5 ml ice-cold TCA (12.5% w/v).
p-Nitrophenol hydroxylase 2.2.7.1.5
The CYP2E1 catalyses the hydroxylation of p-nitrophenol to nitrocatechol and was 
determined according to the method of Reinke and Moyer (1985), as modified by McCoy 
and Koop (1988).
The following reagent mixture was prepared in LP3 tubes in duplicate:
Potassium phosphate buffer (0.2 M, pH 6.8) 500 pi
Ascorbic acid (10 mM) 100 pi
^-Nitrophenol (1 mM) 100 pi
Microsomal fraction (25% w/v) 200 pi
Samples were allowed to equilibrate at 37 °C for 5 min in a shaking water bath. The 
reaction was initiated by the addition of 100 pi NADPH (lOmM in 1% NaHCOs). Samples 
were mixed and incubated at 37 °C for 30 min in a shaking water bath. The reaction was 
arrested by the addition of 0.5 ml ice-cool perchloric acid (0.6 M). Tubes were centrifuged 
at 3,000 g for 10 min using a Beckman J-6 centrifuge. Aliquots of the supernatant (1.0 ml) 
were removed and added to 100 pi of sodium hydroxide (10 M). Samples were mixed and 
the absorbance was measured at 536 nm using an Apel 303 S Japan spectrophotometer. 
Nitrocatechol standards (0-50 nmol) and blank were prepared in the same manner but 
without NADPH and the volume was adjusted with potassium phosphate buffer (0.2 M).
39
Characterisation of Phase II enzymes activities 1 2 ,1.1 
glutathione S-transferase activity 2.2.7.2.1
The glutathione S-transferase enzyme catalyses the conjugation of endogenous 
electrophilic xenobiotics or their metabolites with glutathione. Thus these enzymes play an 
important role in the detoxication of biologically reactive electrophiles. The activity of 
glutathione S-transferase was determined according to the method of Habig et al, (1974). 
The two substrates used in this assay were 3, 4- dichloro-nitrobenzene (DCNB) and 1- 
chloro-2, 4-dintrobenzene (CDNB).
i) Using DCNB as substrate 
.Reagents and assay procedure
The reaction mixture was prepared in two cuvettes as follows:
Test Blank
Potassium phosphate buffer (0. IM, pH7.5) 1.8ml 1.8 ml
DCNB (25mM in 96% ethanol) 0.1ml 0.1ml
Reduced glutathione (25mM in 1.15% w/v KCL) 0.5ml 0.5ml
After establishing a baseline, the reaction was initiated by the addition of 100 pi of the 
diluted cytosol (1: 4) to the test cuvette and the reaction was read at 345nm using a Cecil 
Instruments 860 spectrophotometer. The specific activity of glutathione-S-transferase was
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calculated using the extinction co-efficient of the nitrophenyl-glutathione conjugates at 8.5 
mM"' cm"'
ii) Using CDNB as substrate 
Reagent and assay procedure
The reaction mixture was prepared in two cuvettes as follows:
Test Blank
Potassium phosphate buffer (O.IM; pH 7.5) 1.8ml 1.8 ml
CDNB (25mM in 96% ethanol) 0.1ml 0.1ml
Reduced glutathione ( 5mM in 0.15 M KCL) 0.5ml 0.5ml
The baseline was recorded using the Cecil Instruments spectrophotometer . The reaction 
was initiated by the addition of 100 ul of the diluted cytosol (1:100) to the test cuvette, then 
the reaction was followed at 340 nm. The activity of glutathione-S-transferase was 
calculated using the extinction coefficient of 2, 4-dinitrophenyl -  glutathione, which is 9.6 
mM"' cm"'.
Sulphotransferase 1.1.12.2
The activity of sulphotransferase was measured according to the method of Sakura et al, 
(1981). The activity was determined using 2-naphthol as a substrate and measured
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colourimetrically. The method depend on the conjugation of 2-naphthol to form the 
corresponding 1-naphthyl sulphate, in the presence of a sulphate donor molecule such as 3 
'-phosphoadenosine 5 '- phosphosulphate (PAPS).
Reagents and assay procedure:
Sodium phosphate buffer (0. IM, pH 7.4) 100 pi
2-naphthol (ImM in 75% [v/v] acetone) 100 pi
2 Mercoptoethanol (0. IM in 0.1 M potassium phosphate buffer) 20 pi
PAPS (2mM in OIM Potassium phosphate buffer) 40 pi
Methylene blue (250 mg in 1 L distilled water containing 50 g
Anhydrous sodium sulphate and 10 ml conc.H2S0 4 ) 0.5ml
The reaction was initiated by addition of (100 pi) cytosol and incubated for 30 minutes at 
37°C, the reaction was stopped with methylene blue solution (0.5ml), followed by 2ml of 
chloroform. After mixing, the suspension was centrifuged at 2000g for 10 minutes. The 
chloroform layer was transferred to a tube containing 50 mg of anhydrous sodium sulphate. 
The absorbance was measured at 615 nm using a Cecil Instruments 860 spectrophotometer. 
Sulphotransferase enzyme activity was calculated on the basis that Ipmol of 1-naphthol 
sulphate has an absorbance of 30 units.
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UDP-glucuronosyl transferase 22.1.23
The microsomal glucuronosyl transferase family of enzymes is associated with the 
metabolism and excretion of numerous xenobiotics. The enzyme activity was determined 
using the substrate 2-aminophenol, and the activity was measured by monitoring the 
glucuronidation of 2-aminophenal to the corresponding glucuronide conjugate. The assay 
was carried out according to the procedure described by Burchell, (1974).
Reagents:
Tris-HCL buffer (0. IM pH 8.0) 8 ml.
MgCL(0.15M) 1ml
Triton X (1% w/v) 0.5 ml
Ascorbic acid (0.02M) 1.0 ml
UDP-glucuronic acid 10 pg
One ml of the above mixture was added to 0.5ml of 2-aminophenol (ImM) in a test tube, 
and placed in a water bath at 37 °C for approximately 2 min .The reaction was initiated by
addition of 0.5ml of microsomal suspension (25% w/v) and incubated for 30 min at 37 °C.
The reaction was stopped by addition of 1.0ml of ice-cold TCA (20%w/v in 0.1 M 
potassium phosphate buffer pH 2.7). The tubes were allowed to stand 5 min and then 
centrifuged at 2,500 g for 10 min. To 1.0 ml supernatant, 0.5ml of freshly made sodium 
nitrite (1% w/v) was added. Tubes were vortexed and allowed to stand for 2 min and 0.5ml 
of ammonium sulphmate (0.5% w/v) was then added. Samples were mixed and allowed to
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stand for a further 3 min., after which 0.5ml of N-naphthylethylene diamine (0.1%w/v) was 
added. After mixing, tubes were allowed to stand in a dark room, at room temperature for 
60 min, and absorbance was then measured at 540 nm using a Cecil Instruments 860 
spectrophotometer. The standard curve was constructed using different concentrations (0- 
100 nmoles) of O.lmM aniline in 6% TCA.
2.1.1.2A Epoxide hydrolase
The principle of determination is based on the hydrolysis of benzopyrene 4, 5 epoxide, 
mediated by microsomal epoxide hydrolase, to the corresponding dihydrodiol and was 
determined fluorimetrically. The assay for the activity of epoxide hydrolase assay was 
performed according to the procedure of Dansette et al, (1979).
The following reagents were prepared in a 3 ml fluorimeter cuvette:
Tris-HCL buffer (0.015M; pH 8.7 at 37° C) 2.0ml
Benzo(a) pyrene 4, 5-epoxide (2mM in acetonitrile). 10 pi.
Microsomal fraction (25% w/v) 50 pi.
The cuvette contents were mixed and the increase in fluorescence with time was monitored 
utilizing a Perkin-Elmer LS5 Luminescence spectrophotometer, set at an excitation 
wavelength of 310 nm and an emission wavelength of 385 nm (slit width 2.5mm). 
Enzyme activity was calculated using a standard plot, by replacing benzo(a) pyrene 4, 5- 
epoxide in the reaction mixture with benzo(a)pyrene-4,5-/ran5'-dihydrodiol.
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Western Blot analysis for protein quantification 2.2.8
This involved the separation of polypeptides in gels, followed by electrophoretic transfer of 
the separated polypeptides to an immunobilising nitrocellulose membrane. Antibodies 
were then used to identify specific polypeptides by probing the membrane (Towbin et al 
1979, modified by Burnette 1981).
Preparation of SDS-polyacrylamlde gels 2.2.8.1
All Western Blot equipment, including glass plates, spacers, and combs were thoroughly 
washed with 70% ethanol. At either edge of a large/ small sandwich of plates, spacers
were placed and the glass sandwiches were clipped onto a vertical stand, to aid the pouring
of gels. A resolving gel was prepared as follows:
Milli-Q grade water 5.43 ml
Resolving gel buffer 4.50 ml
Acrylamide (40% w/v) 5.62 ml
Rw-acrylamide 2.95 ml
A/A/A'A'-Tetramethylethylenediamine (TEMED) 18 pi
Freshly prepared ammonium persulphate solution (10% w/v) 180 pi
The resolving gel buffer comprised Tris-HCI (1.5M), pH 8.8, containing 0.4% (w/v) 
sodium dodecyl sulphate (SDS). After the gel components were mixed, the mixture was 
poured between the glass plates to the appropriate height, as indicated on the equipment.
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An aliquot of Milli-Q water (1ml) was also pipetted on top of the resolving gel during 
solidification. This results in a smooth, horizontal surface to which the stacking gel can be 
applied and also prevents the resolving gel fi*om drying. Once set, the water was drained 
off and any excess water removed using filter paper. One comb per gel (8 wells) was then 
slotted into the air space above the resolving gel. Preparation of a stacking gel was as 
follows:
Milli-Q grade water 7.15ml
Stacking gel buffer ' 2.50ml
Acrylamide (40% w/v) 0.75ml
Bis-acrylamide 0.40ml
A,A,A',A’-Tetramethylethylenediamine (TEMED) lOpl
Freshly prepared ammonium persulphate solution ( 10% w/v) 50pl
The stacking gel buffer comprised Tris-HCI (0.5M), pH 6.8, containing 0.4% (w/v) SDS. 
Ensuring there were no air bubbles, the gel was carefully pipetted on top of the resolving 
gel until the comb indentations were covered, and were then allowed to solidify whilst the 
samples were being prepared.
Samples Preparation and gel loading 2.2.S.2
Equal volumes of microsomal or cytosolic protein,were derived from i) S9 
preparations from the control group (5 rats) and ii) S9 preparations from the Doash- treated 
animal group (5 rats), and were then pooled. Protein concentration was determined
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according to the Lowry method (section 2.2.7). Proteins were diluted with phosphate-
buffered saline (PBS), pH 7.5, to a final concentration of Img/ml and diluted further (1:1)
with a loading buffer. The loading buffer, was prepared freshly and contained:
Milli-Q water 4.80ml
Tris-HCI (0.5M), pH 6.8 1.20ml
Glycerol 0.96ml
SDS (10% w/v) 1.92ml
p-Mercaptoethanol 0.48ml
Pyronin Y (0.05% w/v) 0.60ml
The protein/loading buffer mix was heated on a temperature block at 100 °C for 5 minutes 
and, once cooled, centrifuged for 10 minutes at 3000 x g. Meanwhile, the gels were 
transferred to the electrode mount, which had been placed in an electrophoresis tank, 
containing a 1 in 5 dilution of the running buffer. The stock running buffer (5X) consisted 
of 0.12 M Tris, 0.35M glycine and 0.017 M SDS, in a final volume of 1 liter, pH 8.3. After 
the combs were carefully removed, samples (10|il) were loaded into each well. The gels 
were run for 90 minutes, or until the pink dye of the loading buffer had nearly reached the 
base of the plate, with the electrophoresis pack being set at a constant current of 40 mA and 
a voltage of 120V. The electrophoresis mount was then disconnected from the power pack, 
and the gels removed by carefully twisting the combs to release the surrounding glass 
plates.
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2.2.S.3 Transfer of protein to nitrocellulose membrane
The stacking gel was carefully scraped away and the remaining gel was carefully stacked 
between blotting paper and Scotchbrite pads. In addition, there was immediate contact 
between the gel and a nitrocellulose membrane, so that they were touching (Figure 2.2). 
This sandwich was placed in a clean cassette, always ensuring that the materials were 
immersed in a transfer buffer and there were no air bubbles. The transfer buffer comprised 
Tris-HCI (16mM), pH 8.3, with a final concentration of glycine (120 mM) and methanol 
(20% v/v).
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Figure 2.2 Schematic representation of gel stacking procedure
www.fermentas.com/img/blotting.gif
The cassettes were transferred to the electrophoresis tank containing the transfer buffer, and 
transfer of protein to the nitrocellulose membrane occurred over 15 hours, at a constant 
current of 100 mA and a voltage of 120V, after which the cassettes were removed and the 
membranes retrieved.
Immunodetection and visualisation 2.2.8.4
The membrane was transferred into a sterile 50 ml tube, with the protein side curled inside 
and, using a total volume of 10 ml of the relevant reagent, was treated as follows:
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Block membrane
Membrane was incubated in the blocking reagent [5% (w/v) skimmed milk powder in Tris 
buffered saline (TBS)-Tween (0.1% w/w)] 1 hour
Wash
Membrane was washed with TBS-Tween 3 times x 10 min
Addition of primary antibody 1 hour
Membrane was incubated with primary antibody, diluted in diluent [1% (w/v) skimmed milk 
powder in TBS-Tween (0.1% w/w)]
Wash
Membrane was washed with TBS-Tween 3 times x 10 min
Addition of secondary antibody 1 hour
Membrane was incubated with the antibody diluted in diluent
Wash
Membrane was washed with TBS-Tween 3timex 10 min
Finally, the apoprotein bands were developed by adding the substrate buffer (0.1 g 3.3- 
diaminobenzidine in 100 ml of M Tris-HCL buffer, pH 7.5 containing 40 pi of 30% H 2O2). 
The reaction was terminated by washing several times with distilled water, after which the 
bands became visible. Specific proteins were recognised by comparison with the stained 
SDS molecular marker, which consists of 9 standard proteins conjugated to a blue dye, as
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shown in (Table 2.3), and the immunoblots were quantified by densitometry, using the 
GeneTool software version 3.07 (Syngene Corporation, Cambridge, U.K).
Table 2.3 Prestained SDS-PAGE Molecular Weight Markers
Protein Molecular Weight
Myosin 200,000
(3-galactosidase 116,250
Phosphorylase b 97,400
Serium albumin 66,200
Ovalbumin 45,000
Carbonic anhydrase 31,000
Trypsin inhibitor 21,500
Lysozyme 14,400
Aprotinin 6,500
Statistical evaluation 2.2,9
Results for all assays were expressed as mean ± SD, and analysed using the Student’s t-test.
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CHAPTER 3
Evaluation of the in vitro antimutagenic
potential 
of aqueous extracts of Doash tea
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Introduction 3.1
Since ancient civilization, people in all parts of the globe have been using plants and 
their products to counteract various health problems and diseases. This old and traditional 
approach of herbal therapy has progressed from an area of empiricism to the present age of
specific therapeutic agents ( Jyoti et al.,2009).It is only recently that extraction, isolation, 
separation and chemical identification of active ingredients in plants has occurred, and their 
biological functions have been uncovered. Nevertheless, many people, especially in 
traditional societies, continue to use herbal and other medicinal plants as health remedies or 
health promoters, despite no prior knowledge of either their chemical constituents or their 
modes of action. A typical example of this old practice is the use of a local endogenous 
herbal plant from the mint family, called ‘Doash’ or ‘Bardakush’ in Arabic {Origanum 
majorana L.).
The role of diet in human cancer, such as the potential of Doash tea to play an important 
role against mutagenicity and carcinogenicity will be discussed and evaluated in the 
present study, and the following experimental studies will be undertaken.
1- To assess the safety of Doash drinks in terms of mutagenecity in the Ames test.
2- To determine the possible antimutagenic activity of Doash aqueous extracts against 
several known mutagens belonging to different chemical classes. These classes are: 
heterocyclic amines (IQ, PhIP), polycyclic aromatic hydrocarbon (benzo[a]pyrene), 
nitrosamines (nitrosopipridine and nitrosopyrrolidine). Studies will also be carried out
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using a direct-acting carcinogen (9-aminoacridine and MNNG). Assessment of 
antimutagenicity will be using the Ames test and the four bacterial strains of Salmonella 
typhimurium TA97, TA98, TAIOO, and TA1530.
3- To explore the possible underlying biochemical mechanism for the antimutagenic 
activity of Doash extract by:
a- Investigating its ability to modulate the biotransforming activities of some of the 
cytochrome P450 enzymes, specifically CYPlAl (using ethoxyresorufin as a substrate), 
CYP1A2 (using methoxyresorufin as a substrate), CYP2B1 (using pentoxyresorufin as a 
substrate), and CYP2E1 or p-nitrophenol hydroxylase (using p-nitrophenol as a substrate).
b- Investigating the ability of the Doash extract to scavenge any reactive intermediates 
that might be produced during the biotransformation of mutagens and carcinogens.
4- To evaluate the effect of Doash administration on cytochrome P450 and phase II 
conjugation in the liver of rats.
Methods 3.2 
Animals 3.2.1
Male Wistar albino rats (180-200 g) were used in all animal studies. Animals were 
housed in controlled conditions at the animal facilities at the King Fahid Medical Research 
Centre, Jeddah. Lighting cycles were set at 12hr, temperature 22 ± 1 °C, 50% humidity, 
and animals were offered free access to drinking water and standard rodent diet.
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Preparation of fresh Doash 3.2.2
Fresh Doash plants were purchased from the local market in Jeddah. Infusions (2% w/v) 
were prepared by adding 100 ml sterilized, boiling water to Doash plant (2g) in a thermous 
flask for 10 min as brewing time, then filtering it through cotton wool. The infusion 
extracts were stored at 4°C for a maximum of Iday. All Doash concentrations used in this 
study, were applied as different volumes of 50, 100, 250 and 500 p.1, corresponding to 50, 
100, 250 and 500mg respectively. Lower concentrations were used in the case of P- 
nitrohydroxylase activity (10-160jil volumes).
3.2.3 Preparation of dry Doash extract
Dry Doash extract from infusions made for different brewing times (2, 5, 10, 15, 20, 25, 30, 
35, 40, 45 minutes) was prepared by lyophilisation, and then stored at -20°C until use.
.Antimutagenic effect of fresh and dry Doash extract 3.2.4
a) Effect of fresh Doash extract.
This was tested by using the Ames test for Doash tea extract against four carcinogens 
benzo (a) pyrene, IQ, MNNG and nitrosopiperidine.
b) Effect of dry Doash extract
This was tested by using the Ames test for Doash tea extract against only the carcinogen 
IQ. (The antimutagenic activity of Doash extract was described in resultsChaptcr -2.)
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Induction of hepatic microsomal enzymes 3.2.5 
Aroclor 1254 induction 3.2.5.1
Aroclor 1254-treated rats were purchased from the University of Surrey, Guildford, Surrey, 
.UK
Isoniazid induction 3.2.S.2
Isoniazid-treated rats were purchased from the University of Surrey, Guildford, Surrey, 
UK.
Preparation of hepatic sub-cellular fractions 3.2.6
In the present studies, S9 and microsomal fraction, which had been prepared in our 
laboratory, were used together with the one provided by Dr.Costas loannides.
The Ames test 3.2.7
The mutagenic potential was determined using the Ames test according to the method of 
Maron and Ames (1983) described in detail in Chapter 2. Four histidine-requiring bacterial 
strains (TA98, TA97, TAIOO and TA1530) were used in the present study. A metabolic 
activation system containing 10% (v/v) of the hepatic fraction was used and is referred to 
as a 10% activation system. The activation system has been described in detail in Chapter 
2 (Section 2.2.6.8).
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Determination of protein concentration 3.2.8
The protein content of tissue samples was measured using the method of Lowry et ah, 
(1951), using bovine serum albumin as standard. (Section 2.2.7).
Assays of cytochrome P-450 enzymes 3.2.9
A number of assays were used to determine the activity of individual cytochrome P450 
enzymes (CYPs). All assays were carried out in duplicate, including appropriate blanks 
and standards.
Ethoxyresorufin O-deethylase (EROD) activity 3.2.9.1
Burke & Mayer’s (1974) method was used to determine EROD activity, where the 
production of resorufin from the de-ethylation of ethoxyresorufin was measured
fluorometrically, as previously described (Section 2.2.7.1.1).
Methoxyresorufin O-demethylase (MROD) activity 3.2.9.2
The method used is essentially that of Burke & Mayer (1974), where the production of 
resorufin from the déméthylation of methoxyresorufin is measured fluorometrically, as 
described in Section 2.2.7.1.2.
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Pentoxyresorufin O-depentylase (PROD) activity 3.2.9.S
The method used is essentially that of Lubet et al. (1985), where the production of 
resorufin from the depentylation of pentoxyresorufin was measured fiuorometrically, as 
described in Section 2.2.7.1.3.
p-Nitrophenol hydroxylase activity 3.2.9.4
The hydroxylation of /?-nitrophenol by cytochrome P450-catalyzed reaction produces 
nitrocatechol. This conversion, mediated by p-nitrophenol hydroxylase, was determined 
using the method of Reinke & Mayer (1985) as modified by McCoy & Koop (1988), and is 
described in Section 2.2.7.1.5.
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Results 3.3
Effect of the antimutagenic activity of brewing time of Doash 3.3.1 
extract
a) By using fresh Doash extract
The objective of these studies was to evaluate the effect of brewing on the antimutagenic 
activity of fresh Doash extract, using four carcinogens, namely benzo(a)pyrene, IQ, MNNG 
and nitrosopiperidine. Results are shown in (Figures 3.1- 3.4).
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Fig 3.1 The effect of Doash brewing time on the antimutagenic activity towards 
benzo[a]pyrene. This study was carried out using S. typhimurium TAIOO, in the presence
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of benzo (a) pyrene (25ug/plate) and an activation system (10% v/v) derived from Aroclor 
1254-induced rats. Results are presented as means ± SD of triplicate plates. The 
spontaneous reversion rate of 121 ± 2 had already be subtracted.
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Fig 3.2 The effect of doash brewing time on its antimutagenic activity against IQ. This 
study was carried out using S. typhimurium TA98, in the presence of IQ (lOng/plate) and 
an activation system (10% v/v) derived from Aroclor 1254-induced rats. Results are 
presented as means ± SD of triplicate plates. The spontaneous reversion rate of 44 ± 5 had 
already be subtracted.
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Fig 3.3 The effect of Doash brewing time by using MNNG. This study was carried out 
using S. typhimurium TAIOO, in the presence of MNNG (lug/plate). Results are presented
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as means ± SD of triplicate plates. The spontaneous reversion rate of 146 ± 4 had already 
be subtracted.
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Fig 3.4 The effect of Doash brewing time by using Nitrosopiperidine. This study was 
carried out using S. typhimurium TA1530, in the presence of nitrosopiperidine (6mg/plate) 
and an activation system (25% v/v) derived from isoniazed-induced rats. Results are 
presented as means ± SD of triplicate plates. The spontaneous reversion rate of 14±2 had 
already be subtracted.
b) By using dry Doash extract
The effect of brewing time on the antimutagenic activity of dry Doash extract against 
IQ was tested. The results revealed that a brewing time of 20-25 min resulted in maximum 
antimutagenic effect. Thus, a brewing time of about 25 minutes results in the release of the 
optimal amount of active antimutagenic component (Figure 3.5).
61
600
500
400
t  300
B% 200
3® 100
0 10 20 30 40 50
Brewing time(minutes)
Fig 3.5 The effect of brewing time on dry doash extract on its antimutagenic activity 
against IQ. This study was carried out using S. typhimurium TA98, in the presence of IQ 
(lOng/plate) and an activation system (10% v/v) derived from Aroclor 1254-induced rats. 
Results are presented as means ± SD of triplicate plates. The spontaneous reversion rate of 
39 ± 1 has been subtracted.
Doash antimutagenic activity 3.3.2
Doash aqueous extracts, prepared in the same fashion as consumed locally (2%, w/v), 
were examined for mutagenicity and antimutagenicity using the Ames test, with four 
different bacterial strains (TA97, TA98, TAIOO, TA1530). None of the strains tested 
revealed any mutagenic activity for Doash extract, either with or without the addition of the 
metabolic activating system (results not shown).
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On the other hand, the Doash extract caused marked and concentration-dependent 
antimutagenic activities against various chemical mutagens and belonging to various 
chemical classes, such as heterocyclic amines; IQ (2-amino-3-methylimidazo-quinolidine) 
and PhIP (2-amino-l-methyl-6-phenylamide azo [4,5,6] pyridine), polycyclic aromatic 
hydrocarbons; benzo [ajpyrene and 7,12-dimethylbenz[a]anthracene, nitrosoamines; 
nitrosopyrrolidine and nitrosopiperidine, together with the direct-acting carcinogens; 
MNNG (A-methyl-iV-nitro-A-nitrosoguanidine)) and 9-aminoacridine.
Antimutagenic activity of Doash extract against IQ 3.3.3
Figure 3.6 shows the mutagenic activity of IQ (10 -50 ng) against S. typhimurium TA98 and 
10% (w/v) hepatic S9 preparation from Aroclor 1254-induced rats as an activation system. 
The relationship between IQ and mutagenicity was concentration dependent (5-50ng/plate) 
showing a linear trend.
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Figure 3.6 The mutagenic activity of IQ. This study was carried out using S. 
typhimurium TA98, in the presence of IQ and an activation system (10% v/v) derived from 
Aroclor 1254-induced rats. Results are presented as means ± SD of triplicate plates. The 
spontaneous reversion rate of 44 ±5 has already been subtracted. '
Doash extract (2%, w/v) showed a strong antimutagenic effect in S. typhimurum TA98 
when IQ (lOng) was used as a model mutagen in the presence of 10% (w/v) hepatic S9 
preparation from Aroclor 1254-induced rats, as an activation system (Figure 3.7). The 
relationship between Doash extract and antimutagenesis against IQ was concentration 
dependent (Figure 3.7).
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Figure 3.7 Antimutagenic activity of Doash against IQ. Study carried out using a range 
of volumes of Doash (2% w/v) and IQ (lOng) as the mutagen in a strain of S. typhimurium 
TA98. Results are presented as means ± SD of triplicates. The spontaneous reversion rate 
of 36 ±2.0 has already been subtracted.
Antimutagenic activity of Doash against PhIP 3.3.4
The mutagenic activity of PhIP (2-amino-1 -methyl-6-phenylimidazo[4,5,6] pyridine) 
against S. typhimurum TA98 and 10% hepatic S9 preparation, from Aroclor 1254-induced 
rats as an activation system. A strong reversion rate was produced as the concentration of 
PhIP increased, from 0-100 ug/plate. (Figure 3.8)
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Figure 3.8 The mutagenic activity of PhIP This study was carried out using S. 
typhimurium TA98, in the presence of PhIP and an activation system (10% v/v) derived 
from Aroclor 1254-induced rats. Results are presented as means ± SD of triplicate plates. 
The spontaneous reversion rate of 37 ±2 has already been subtracted
Doash extract also showed a potent antimutagenic activity when tested against PhlP- 
induced mutagenesis. Figure 3.9 shows a similar pattern of antimutagenicity, as previously 
produced by IQ. Thus, as the Doash concentration increases, antimutagenic activity is 
more pronounced.
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Figure 3.9 Antimutagenic activity of doash against PhIP. Study was conducted using a 
range of volumes of Doash (2% w/v) and PhIP (lOug) as the mutagen in a strain of 
S. typhimurium TA98, and 10% hepatic S9 preparation from Aroclor 1254-induced rats. 
Results are presented as means ± SD of triplicates. Spontaneous reversion rate of 36 ± 2.0 
had aheady been subtracted.
Antimutagenic activity of Doash against benzo [a]pyrene 3.3.5
Doash extracts were also effective against the mutagenic activity of the polycyclic 
aromatic hydrocarbon benzo [ajpyrene (BP). This compound (lO-lOOug/plate) was an 
effective mutagen against S. typhimurum TAIOO in the presence of 10% (w/v) hepatic S9
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activation system, obtained from Aroclor 1254-induced rats as an activation system (Figure 
3.10).
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Figure 3.10 The mutagenic activity of benzo(a)pyrene. This study was carried out using 
S. typhimurium TAIOO, in the presence of benzo(a)pyrene and an activation system (10% 
v/v) derived from Aroclor 1254-induced rats. Results are presented as means ± SD of 
triplicate plates. The spontaneous reversion rate of 138 ±1 has already been subtracted
Doash extracts (50-500ul) were also effective in antimutagenic effect of benzo(a)pyrene 
(25ug ) (Figure 3.11).
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Figure 3.11 The antimutagenic activity of Doash extract. Study was conducted using a 
range of volumes of Doash (2% w/v) and benzo(a)pyrene (lOug) as the mutagen in a strain 
of S.typhimurium TA98, and 10% hepatic 89 preparation from Aroclor 1254-induced rats. 
Results are presented as means ± SD of triplicates. Spontaneous reversion rate of 114 ± 2 
had already been subtracted.
Antimutagenic activity of Doash extract against 7,12 3.3.6 
dimethylbenz(a) anthracene
Figure 3.12 shows the mutagenic affect of one of the potent mutagens, belonging to the 
polycyclic aromatic hydrocarbons, 7,12 dimethylbenz(a)anthracene against S. typhimurium 
TAIOO, when a 10% (v/v) hepatic S9 preparation from Aroclor 1254-induced rats is used 
as an activation system.
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Figure 3.12 The mutagenic activity of 7,12 dimethylbenz(a)anthracene. This study was 
carried out using S. typhimurium TAIOO, in the presence of 7,12 
dimethylbenz(a)anthracene and an activation system (10% v/v) derived from Aroclor 
1254-induced rats. Results are presented as means ± SD of triplicate plates. The 
spontaneous reversion rate o f  106 ±11 has aheady been subtracted
Doash extracts were effective in suppressing the mutagenic effect of 7,12 
dimethylbenz(a)anthracene (Figure 3.13).
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Figure 3.13 The antimutagenic activity of Doash extract. Study was conducted using a 
range of volumes of Doash (2% w/v) and 7,12 dimethylbenz(a)anthracene (50ug) as the 
mutagen in a strain of S.typhimurium TAIOO, and 10% hepatic S9 preparation from Aroclor 
1254-induced rats. Results are presented as means ± SD of triplicates. Spontaneous 
reversion rate of 155 ± 7 had already been subtracted.
Antimutagenic activity of Doash against nitrosopyrrolidine 3.3.7
Two mutagens belonging to the nitrosoamines (nitrosopyrrolidine and 
nitrosopiperidine) were used in this study. Figure 3.14(a) shows the mutagenic activity of 
nitrosopyrrolidine against S.typhimurium TA1530 in the presence of 25% v/v hepatic S9 
preparation from Isoniazid-treated rats, as an activation system. The relationship between 
nitrosopyrrolidine and mutagenicity was concentration dependent, showing almost a linear 
dose-response relationship.
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Figure 3.14 (a) The mutagenic activity of nitrosopyrrolidine. This study was carried out 
using S. typhimurium TA1530, in the presence of nitrosopyrrolidine and an activation 
system (25% v/v) derived from isoniazed-induced rats. Results are presented as means ±
SD of triplicate plates. The spontaneous reversion rate of 31±2 had already be subtracted.
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Figure 3.14 (b) The antimutagenic activity of Doash. Study was conducted using a 
range of volumes of Doash (2% w/v) and nitrosopyrrolidine (6mg) as the mutagen in a 
strain of S.typhimurium TA1530, and 25% hepatic S9 preparation from isoniazid-treated 
rats. Results are presented as means ± SD of triplicates. Spontaneous reversion rate of 34± 
2 had already been subtracted.
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Doash extract (2%) showed an antimutagenic effect in the Ames test when 
nitrosopyrrolidine (6 mg) was used as a mutagen (Figure 3.14 (b). The relationship between 
Doash extract and antimutagenesis, against nitrosopyrrolidine, was concentration 
dependent (50-500ul).
Antimutagenic activity of Doash extract against 3.3.8 
nitrosopiperidine
Figure 3.15 (a) shows the mutagenic activity of nitrosopiperidine (2-10 mg/plate) in S. 
typhimurium TA1530 in the presence of 25% (w/v) hepatic S9 preparation from isoniazid- 
treated rats, as an activation system.
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Figure 3.15 (a) The mutagenic activity of nitrosopiperidine. This study was carried out 
using S. typhimurium TA1530, in the presence of nitrosopiperidine and an activation 
system (25% v/v) derived from isoniazed-induced rats. Results are presented as means ± 
SD of triplicate plates. The spontaneous reversion rate of 23±1 had already subtracted.
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Fig. 3.15 (b) The antimutagenic activity of Doash. Study was conducted using a range of 
volumes of Doash (2% w/v) and nitrosopyrrolidine (4mg) and (6mg) as the mutagen in a 
strain of S.typhimurium TA1530, and 25% hepatic 89 preparation from isoniazid-treated 
rats. Results are presented as means ± SD of triplicates. Spontaneous reversion rate of 25± 
1 had aheady been subtracted.
Doash extracts were also effective in reversing the mutagenic affect of nitrosopiperidine in 
a concentration-dependent manner (Figure 3.15 b).
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Antimutagenic activity of Doash against MNNG 3.3.9
Figure 3.16 shows the mutagenic activity of the direct-acting carcinogen 7V-methyl-#'- 
nitro-jV-nitrosoguanidine) (MNNG) in S.typhimurium TAIOO. The relationship between 
MNNG and mutagenicity was linear (Figure 3.16).
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Figure 3.16 The mutagenic activity of MNNG. This study was carried out using S. 
typhimurium TAIOO, in the presence of MNNG. Results are presented as means ± SD of 
triplicate plates. The spontaneous reversion rate of 83±2 had already be subtracted.
Doash extract (2%, w/v) showed an antimutagenic effect toward MNNG (lug) (Figure 
3.17). The relationship between Doash extract concentration and antimutagenic activity.
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Figure 3.17 The antimutagenic activity of Doash towards MNNG. Study was conducted 
using a range of volumes of Doash (2% w/v) and MNNG (lug/plate) as the mutagen in a 
strain of S.typhimurium TA 100.Results are presented as means ± SD of triplicates. 
Spontaneous reversion rate of 125± 13 had aheady been subtracted
Antimutagenic activity of Doash extract against 9- 3.3.10 
aminoacridine
Figure 3.18 shows the mutagenic activity of another direct-acting carcinogen, 9- 
aminoacridine, in S.typhimurium TA97. Doash extract showed a significant antimutagenic 
effect against 9- aminoacridine (50 ug), (Figure 3.19). The relationship between Doash 
extract (50-500 ul) and antimutagenesis against 9- aminoacridine was concentration 
dependent.
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Figure 3.18 The mutagenic activity of 9-aminoacridine. This study was carried out using 
S. typhimurium TA97, in the presence of 9-aminoacridine. Results are presented as means 
± SD of triplicate plates. The spontaneous reversion rate of 164±5 had already be 
subtracted.
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Fig 3.19 The antimutagenic activity of Doash. Study was conducted using a range of 
volumes of Doash (2% w/v) and 9-aminoacridine (50 ug) as the mutagen in a strain of 
S.typhimurium TA97.Results are presented as means ± SD of triplicates. Spontaneous 
reversion rate of 176± 6 had already been subtracted
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Scavenging of genotoxic effect of mutagenes by aqueous Doash 3.3.11 
extract
In order to determine the ability of the Doash extract to scavenge electrophiles 
generated metabolically, the Ames procedure was modified. A carcinogen, appropriate 
activation system and fresh bacterial culture were incubated in a shaking water-bath at 37°C 
for 20 min. The microsomal metabolism was terminated by the addition of menadione, 
aqueous tea extracts were added and a further 20 min pre-incubation was conducted at 37°C 
to evaluate the potential of Doash extracts to scavenge the mutagenes. It can be seen that 
menadione drastically reduced the mutagenicity of benzo [a] pyrene (Table 3.1) and N- 
nitrosopiperidine (Table 3.2). When microsomal metabolism was terminated by the 
addition of menadione at the end of the first incubation period, incorporation of aqueous 
extracts from the Doash caused a concentration-dependent decrease in the mutagenic 
response of the two model promutagens.
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Table 3.1 Interaction of Doash extract with microsomal-derived genotoxic species of
*(benzo[a]pyrene (BP
3 ±  132
BP - 4 ±  722
BP and menadione - 4 ±  157
BP Menadione 1 ± 271
BP (Menadione and doash ( 50 ul 7 ±  184
BP (Menadione and doash (100 ul 6 ± 162
BP (Menadione and doash (250 ul 8 ±  148
BP (Menadione and doash (500 ul 5 ±  131
The carcinogen (BP) (25ug/plate) was pre-incubated with hepatic microsomes from 
Aroclor-induced rats (10% w/v) and S. typhimurium TA98 for 20 min. (first pre­
incubation). Microsomal activity was terminated by adding menadione (900uM), after 
which Doash aqueous extracts (2% w/v) were added and a further 15 min of incubation 
was allowed (second pre-incubation). Results are presented as mean ± SD of triplicates.
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Table 3.2 Interaction of Doash extract with microsomal-derived genotoxic species of
*(nitrosopiperidine (NP
33±3
NP - 360±3
NP and menadione - 50±4
NP Menadione 103±5
NP (Menadione and Doash (50 ul 74±6
NP (Menadione and Doash (100 ul 51±3
NP (Menadione and Doash (250 ul 35±3
NP (Menadione and Doash (500 ul 17±4
The carcinogen (NP) (4mg/plate) was preincubated with hepatic microsomes from 
Aroclor-induced rats (10% w/v) and S. typhimurium TA1530 for 20 min. (first pre­
incubation). Microsomal activity was terminated by adding menadione ((900uM), after 
which Doash aqueous extracts (2% w/v) were added and a further 15 min. of incubation 
was allowed (second pre-incubation). Results are presented as mean ± SD of triplicates.
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Antimutagenic activity of Doash extract against 7V-OH-IQ 3.3.12
This experiment was carried out to study the antimutagenic effect of different concentration 
of Doash extract (2% w/v), when /V-hydroxylated IQ (by catalyzing the oxidation of IQ to 
N-hydroxy-IQ) was used as mutagen in the Ames test.
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Figure 3.20 Effect of Doash extract against N-OH-IQ (25 ng/plate). This study was 
conducted using a strain of S.typhimurium TA 98. The spontaneous revertants 35±2 had 
already been subtracted. Results are presented as means ± SD of triplicate.
Doash extract (2% w/v) showed an antimutagenic effect against N-OH-IQ (25ng/plate) 
.((Figure 3.20
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Effect of Doash on the 0-dealkylation of alkoxyresorufins 3.3.13
A further investigation was eonducted out to study the affect of Doash extracts on the 
microsomal de-alkylating activity against three alkyloxyresorufins, namely; 
methoxyresorufm, ethoxyresorufin and pentoxyresorufm in Aroclorl254-induced rat 
hepatic microsomes. To modify cytochrome P-450-dependent 1A1,1A2 and 2B 
monooxygenases Doash extract significantly inhibited the 0-dealkylation of both methoxy- 
and ethoxyresorufins (Figures 3.21 and 3.22 respectively). The (9-dealkylation of 
pentoxyresorufm was increase by Doash extract and their declined but was still above 
control activity (Figure 3.23). It was also noted that Doash extract, at the concentration 
used, neither fluoresces nor influences the fluorescence of resorufln, the product of the 
three-dealkylation reactions (results not shown).
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Figure 3.21 Inhibition of hepatic microsomal activity in the O-dcalkylation of 
mcthoxyrcsorufin. The study was carried out by using Doash extract (2% w/v). 
Microsomes were isolated from Aroclor 1254-treated rats.
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Figure 3.22 Inhibition of hepatic microsomal activity in the O-dcalkylation of 
ethoxyresorufin. The study was carried out by using Doash extract (2% w/v). Microsomes 
were isolated from Aroclor 1254-treated rats.
3.5
_c
5)
2
Q .
EQ)
Q .
C
1
I
c
2.5
5 1.5
0.5
0 - I—J 
0 10 20 40 80 100 120
D o a s h  e x t r a c t  (ul)
140 160
Figure 3.23 Changes of hepatic microsomal O-dealkylation of pentoxyresorufin. The
study was carried out by using Doash extract (2% w/v). Microsomes were isolated from 
Aroclor 1254-treated rats.
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Figure 3.24 shows the effect of different concentrations of Doash extract on the 
hydroxylation of p-nitrophenol, mediated by the activity of cytochrome P450-dependent 
mixed function oxidase CYP2E1. Nitrocatechol, which is formed by this reaction, is 
measured at 536nm in the presence of lOOul NADPH (lOmM).
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Figure 3.24 Affect of Doash extract concentration (O-lOOul) on the hydroxylation of p- 
nitrophenol.
The results show a strong inhibitory effect of Doash extract against p-nitrophenol 
hydroxylase activity, as its concentration increases from 5 to lOOul.
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Discussion 3.4
Since Doash extract shows that it modulates the process of mutagenesis and prevents 
genotoxicity, we have attempted to explain the biochemical mechanism(s) underlining this 
process. One such explanation for the antimutagenic effect of Doash is the possibility that 
this herb modulates the enzyme activities that mediate the metabolic activation of the 
chemical carcinogens, e.s polycyclic aromatic hydrocarbons, heterocyclic amines and 
nitrosamines (Wang et ah, 1988 & 1992; Chung et ah, 1993; Katiyar et ah, 1993). It is 
possible, therefore, that Doash possesses antimutagenic and anticarcinogenic activities, by 
altering the metabolic course of promutagens and procarcinogens, to favour their ultimate 
detoxication and excretion. Such a mechanism has already been proposed to explain the 
protective action of green tea against mutagenesis and carcinogenesis (Qari 2008).
Cytochrome P450 enzymes are the major biotransforming systems responsible for the 
metabolism of many carcinogens. They are believed to be responsible for the metabolism
of more than 90% of known chemical carcinogens (Bouhdid etal.,2008).
A series of experiments was conducted to determine the effect of Doash extract on the 
activity of four P-450 enzymes that had already been induced by giving rats either the 
potent CYPl inducer, Aroclor 1254, or the potent CYP2 inducer, isoniazid, prior to the 
assays. Aroclor 1254 and isoniazid caused the induction of CYPl and CYPB2E, 
respectively. The CYPl catalyzes the bioactivation of polycyclic aromatic hydrocarbons 
and heterocyclic amines, and CYP2B catalyzes the bioactivation of nitrosoamines, such as
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nitrosopyrrolidine and nitrosopiperidine (McCoy et al., 1979; Yang et al., 1985; Ayrton et 
al., 1987).
The ability of Doash extract to modify P450 enzymic activity was evaluated by using 
three CYP’s, in order to mediate the reactions of three 0-dealkylations, namely, CYPlA l, 
CYP1A2, and CYP2B (Namkung et al., 1989), in addition to CYP2E1, which mediates a 
hydroxylation reaction.
Since the induction of the CYPl family is highly associated with the bioactivation 
of many chemical carcinogens (loannides and Parke, 1990; Christou et al., 1995), it is 
conceivable that Doash may modulate the CYPl-mediated activation of chemical 
carcinogens.
CYP1A2 catalyses the bioactivation of major classes of carcinogens, including: AA 
(aromatic amines), HA (heterocyclic amines) (Kleman and Overvik 1995), MC 
(mycotoxins) NNK (4-(methylnitrosamino)-1 -(3-pyridyl)-1 -butanone and AAB
(aminoazobenzenes) (loannides & Lewis 2004). The heterocyclic amines induce potent 
mutagenic effects, and undergo a bioactivation process catalyzed by CYP1A2 (Kato et ah, 
1983; Abu-Shakra et al., 1986). My results have shown that Doash extract was able to 
reverse the IQ mutagenic effect, which could be explained by its ability to interfere with IQ 
metabolic activation mediated by CYP1A2 via the A-oxidation reaction (loannides and 
Parke 1990). Methoxyresorufin is a probe used to measure CYP1A2 activity (Namkung et 
al., 1988). Doash extract showed a strong inhibitory activity toward this enzyme, in a dose- 
response fashion.
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Similarly, the mutagenic effect of benzo[a]pyrene requires a bioactivation pathway 
mediated by CYPIAI. The 0-deethylation reaction of ethoxyresorufin, mediated by 
CYPlAl, was strongly inhibited by Doash extract and this inhibition was dose dependent.
The inhibition of CYPlAl and CYP1A2 activities by Doash extract suggests a 
potential chemoprevention against carcinogens that require bioactivation by these isoforms. 
The association of elevated GYP levels with chemical carcinogenesis is supported by 
extensive experimental studies (Steele et al., 1985; Nebert 1989; Yano et al., 1989; 
loannides & Parke 1993; Yang 2003).
The (9-depentylation of pentoxyresorufin is selectively catalyzed by CYP2B (Lubet et 
al., 1985; Wang et al., 1992). Unlike the other two dealkylating enzymes, Doash extract 
had a less pronounced effect, as an inhibitor, on CYP2B. Instead, Doash significantly 
stimulated CYP2B activity.
The CYP2E sub-family contains one single enzyme in humans (CYP2E1). Through the 
catalytic action of this enzyme, it generates Reactive Oxygen Species (ROS), which 
destroy cellular membranes and react with biomolecules such as proteins and nucleic acids. 
It also has an extensive role in chemical carcinogenesis (loannides & Lewis 2004). The 
enzyme p-nitrophenol hydroxylase, which catalyses the hydroxylation of p-nitrophenol to 
nitrocatechol, is activated by CYP2E1 (Koop et al., 1989). This isoform is believed to 
mediate the bioactivation of nitrosoamines, such as nitrosopyrrolidine and 
nitrosopiperidine. All Doash extract concentrations used in this study (5-lOOul) were 
effective inhibitors of CYP2E1. In fact, this profound reduction by Doash extract of 
CYPlA l, CYP1A2 and CYP2E1 activities resembles several studies made using green tea
(Stavric et al., 1964; Bu-Abbas et al., 1994 &1997; Steele et al., 1985; Wang et al., 1988; 
Yen & Chen 1996; loannides 1999).
Several studies have shown that some herbs, such as teas of rooibos {Aspalathus 
linearis), honeybush {Cyclopia intermedia) as well as green and black teas have similar 
inhibitory activity against several CYP-450 dependent enzymes (Mamewick et al, 2004). 
Furthermore, some studies have shown that flavonols suppress the cytochrome P450 
system (Steele et al., 1985). The previous results are similar to those reported earlier on 
green tea (Sugimura et al., 1993 and Bu-Abbas et al., 1994). Similar results were reported 
by catechins from green tea using human cytochrome P450, to assess its effects on the 
metabolic activation of four carcinogens (Muto et ah, 2001). Most chemical carcinogens 
requiring bioactivation are able to generate reactive intermediates that interact covalently 
with DNA, to cause genotoxicity that may lead to tumorigenesis (loannides & Parke 1975). 
Therefore, the antimutagenic effect of Doash could be explained, at least in part, by a 
decrease in cytochrome P450-mediated mixed-function oxidase activity.
The present study suggests that the in vitro antimutagenic activity of the Saudi Arabian 
herbal tea, against many food and environmentally borne mutagens and carcinogens, is 
linked to its ability to modulate CYP450-dependent enzymes. It indicates also that the 
inhibitory effect of Doash on the mutagenesis of several dietry-bome mutagens and 
environmental genotoxicants is apparently due to the interference of Doash phytochemicals 
with the metabolic activation of these mutagens and carcinogens. By inhibiting CYP- 
dependent bioactivation reactions of mutagens and carcinogens, DNA damage can be 
prevented. A link between CYP induction and human cancer incidence among smokers
suffering from lung cancer has been reported ( Jyoti etal.,2009)
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Among chemical analysis of green tea revealed prescene of monoterpenes, i) d- 
limonene, which is known to inhibit rat mammary and other tumor development 
(Maltzman et ah, 1989; Crowell et ah, 1994; Chen et ah, 1999), ii) carotenoids, which 
possess antioxidant activity (Nishino et ah, 2005), and iii) vitamins, such as vitamin C (L- 
ascorbic acid) which acts as a competitive inhibitor of nitrosamine formation from nitrate 
and amides (Fong et ah, 1976; Oliveira et ah, 2003), and vitamin E (alpha-tocopherol) 
which acts as a powerful antioxidant with multiple roles (Sung et ah, 2002). Further 
studies are needed to determine the chemical composition of Doash leaves and the most 
active antimutagenic phytochemicals they possess by HPLC/MS techniques.
It should be noted, however, that although the inhibition of bioactivation pathways, 
catalyzed by cytochrome P450-dependent metabolism, may be responsible, at least in part, 
for the antimutagenic effect of Doash, other mechanisms may be involved and these should 
be explored. For example, Doash components may act as scavengers of oxidative free 
radicals, formed during xenobiotic and normal endobiotic metabolism. Scavenging of 
Reactive Oxygen Species (ROS), such as hydroxyl radicals, has been shown to correlate 
with the antimutagenic activity of various teas against food-borne carcinogens (Yen & 
Chen 1995) and during the post-initiation phase of carcinogenesis (Waltenberg 1992). It 
has been shown that green tea also promotes these activities (Rich et ah, 1989; Yuting et 
al., 1990; Xu et al., 1992). The food carcinogen IQ undergoes an activation process 
involving an N-hydroxylation, followed by the estérification of hydroxylamine with 
sulphate and acetate, to generate sulphatoxy and acetoxy esters, respectively (loannides & 
Lewis 2004). The two esters may be excreted, thus diminishing their toxicity, or undergo 
further metabolism to yield the nitrenium ion, the presumed ultimate carcinogen (loannides
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& Lewis 2004). Any factors that disrupt the balance between activation and deactivation 
will eventually alter the delicate balance between the two pathways, and consequently alter 
the toxicity and carcinogenicity of the challenging chemical (loannides & Lewis 2004).
The potential of Doash extract as a scavenger of genotoxic activity through inhibition of 
the mutagenic effect of promutagens due to high terpene contents as detected by HPLC/MS 
analysis when aqueous extracts were incorprated compared with the control menadione 
used.
It was found that Doash extract exerts antimutagenic activity against IQ or N-OH-IQ and 
the inhibition effect is concentration dependent, suggesting that Doash tea may act on 
phase 1 inhibition or by scavenging its product.
In conclusion, Doash extract possesses powerful antimutagenic properties, which 
impair the deleterious effects of various chemicals used in this study. One possible 
mechanism involved in this protection, is the inhibition of the metabolic activation of 
chemical carcinogens, to their reactive metabolites. We also suggest that the health 
benefits of Doash could be derived from the additive and synergistic combinations of the 
various phytochemicals present in Doash leaves.
Other studies should also be conducted to determine the active components of Doash 
leaves, including macro- micronutrients and other phytochemicals. Clinical studies should 
be made before any claim that Doash consumption offers chemoprotection against cancer.
91
CHAPTER 4 
Antimutagenic potential of 
Doash extract 
fractions
92
Introduction 4.1
A number of previous studies have shown that medicinal or food plants may contain 
antimutagenic substances, which can strongly inhibit mutations caused by chemicals 
(Karekar et ah, 2000, Eom et al ., 2007). As a result, studies are currently in progress to 
evaluate the antimutagenic properties of medicinal plants that may prove useful in cancer 
treatment (Kundu and Surh, 2005). Determination, identification and characterisation of 
antimutagenic and anticarcinogenic effects of these compounds, is an important strategy to 
reduce the incidence of cancer in humans. Some bioactive compounds and their 
derivatives have been reported to modulate all stages of chemical carcinogenesis. Research 
has underlined the chemo-preventive activity of several secondary plant metabolites such 
as polyphenols, terpenes and lycopene...(Hom and Vargas, 2003).
Origanum majorana L (Doash) is one traditional remedy that is used in the Kingdom 
of Saudi Arabia as a tea and to treat ailments. So far, the chemical composition, together 
with some biological activities such as antimicrobial and antioxidant properties of Doash, 
have not been extensively studied. It would therefore be of great importance to fractionate 
the Doash aqueous extract, in order to identify the active components of Doash. The 
present study has attempted to evaluate the inhibitory action of Doash fractions on the 
bioactivation of selected food mutagens and direct-acting mutagens.
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Materials 4.2
All chemicals and Salmonella typhimurium strains TA 98, TA 100, TA 97 and TA 1530 
were obtained as previously cited in Chapter 2.
Methods 4.3
4.3.1 Animal pre-treatment
Aroclor 1254- and isoniazid-induced rat liver preparations were obtained from the 
University of Surrey, Guildford, Surrey GU2 7XH. UK.
4.3.2 Total solids determination and HPLC analysis 
Isolation of fractions
An aliquot of the prepared Doash sample (200pl) was injected into the HPLC equipment 
system controller and then the fractions were collected every 5 minutes over a 60-minute 
period. Chromatographic analysis was performed using Agilent 1100 series HPLC LC- 
8A column size 4.6 X 150 mm diameter, preparative liquid chromatograph, SPD-lOA vp 
with UV-vis detector FRC-lOA and fraction collector. C l8, 5pm x 150 mm. A solvent 
gradient was used in order to separate the various fractions: solvent A was composed of 
water: acetonitrile: glacial acetic acid (980:20:5 v/v/v,), and solvent B of acetonitrile: 
glacial acetic acid (995:5 v/v). Solvents were delivered at a total flow rate of 300 pL/min; 
the gradient used is given in table 4.1.
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The fractions were collected and subsequently were dried by rotary evaporation at 40 
°C, under reduced pressure. The dried fractions were stored at - 20°C. Total solids were 
determined by freeze-drying a portion of the whole Doash tea extract or of the different 
isolated fractions (from an aliquot taken before drying by rotary evaporation).
.Table 4.1: Solvent gradient used for the separation of the Doash fractions
(Time (minute Solvent A Solvent B
0 100 0
12 75 25
40 55 45
46 4 96
48 0 100
53 100 0
60 100 0
200pl of Doash sample aliquots were injected into semi-preparative column. Fractions 
were collected every 5 minutes to give 12 fractions. The data were analysed using Spectra 
Focus software on a Compact computer.
4.3.3 HPLC/MS analysis
Further identification of Doash fractions was conducted using the HPLC/MS system at 
the University of Surrey ( Faculty of Health and Medical Sience ) as follows:
Autosampler with 50 pL loop, a photodiode array (PDA) detector recording at 320, 
280 and 254 nm and scanning from 200 to 600 nm was used. This was interfaced with an
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LCQ Deca XP Plus mass spectrometer, fitted with an electrospray ionization (ESI) source 
(Thermo Finnigan), and operating in data-dependent, full scan, MS" mode to obtain 
fragment ion m/z.
MS operating conditions:
• negative ion
• ionization voltage of 5 kV
• capillary temperature 275 °C
• sheath gas flow rate 90 arbitrary units, and
• auxiliary gas flow rate 20 arbitrary units.
Separations were achieved using a Gemini 5 pm phenylhexyl, 150 x 3 mm column 
(Phenonemex, Macclesfield, UK).
Solvent A was water : acetonitrile : glacial acetic acid (980 : 20 : 5 v/v/v, pH 2.7):
Solvent B was acetonitrile : glacial acetic acid (995 : 5 v/v).
Solvents were delivered at a total flow rate of 300 pL/min, and the gradient used is shown 
in table 4.2. below:
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Table 4.2: Solvent gradient used for the separation of Doash fractions in LC/MS
studies
Time Solvent A Solvent B
0 100 0
12 75 25
40 55 45
46 4 96
48 0 100
53 100 0
60 100 0
4.3.4 Evaluation of the antimutagenic activity of Doash fractions
Antimutagenic potential of the Doash fractions was assessed using the Ames test 
(Maron and Ames, 1983) described in detail in Chapter 2. Different strains of S. 
typhimurium TA98, TAIOO, TA97, TA1530 were employed. Activation systems in the 
presence of either Aroclor 1254 or isonazid-induced hepatic S9 fraction were used, in order 
to investigate the possible direct reaction between Doash tea or its fractions (500pi) against 
various types of mutagen: IQ, MNNG, benzo(a) pyrene and nitrosopiperidine. The Ames 
test was employed as described (Section 2.2.6.8), and either Doash tea extracts (500pl) or 
its fractions (500pl) were add with each mutagen. The possible contribution of the solvent 
systems to the antimutagenic activity of the Doash fractions was determined.
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Enzyme assays 4.3.5
Hepatic post-mitochondrial (S9), microsomal and cytosolic fractions were prepared as 
previously described (Section 2.2.5). The O-dealkylation of methoxyresorufin (Burke and 
Mayer, 1974), was determined as described previously in Section 2.2.6.S.
Results 4.4
4.4.1 Characterization of Doash tea fractions
The amount of total solids present in 2% aqueous Doash extract was found to be 4.40 
mg/ml (Table 4.3). The highest active amount of solids, i.e., dry weight of Doash tea, was 
present in fraction No 5, followed by fraction No 4, whereas the other fractions contained a 
relatively low amount. A large peak was recorded at 28 min (fraction No.5) and indicated 
that the most abundant compounds were detected at 254 and 356 nm respectively, at 25 
minutes retention time (Figures 4.1 and 4.2). The total solids mg/fraction were measured in 
comparison to the dry weight extract solids of the whole Doash.
Table 4.3 The relative total solid content of the aqueous Doash fractions (2 % w/v).
%Doash constituent 
(mg/ml)
Total Solid ; Recovery
Doash total extract 4.40±0.03 100%
Fraction 1 0.16±0.02 3.63
Fraction 2 0.48±0.03 10.90
Fraction 3 0.14±0.01 3.18
Fraction 4 0.64±0.03 14.54
Fraction 5 0.72±0.02 16.36
Fraction 6 0.45±0.01 10.22
Fraction 7 0.12±0.01 2.72
Fraction 8 0.19±0.02 4.31
Fraction 9 0.07±0.01 1.59
Fraction 10 O.liO.Ol 2.27
Fraction 11 0.043=0.01 0.90
Fraction 12 0.033=0.02 0.6
*Results are presented as mean± SD of triplicate determination.
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Figures 4.1 & 4.2 Typical HPLC chromatograms of Doash aqueous extracts (2% w/v) 
chromatographic conditions were as in Section 4.3.2. The UV detection scanning was done 
at two wavelengths 254nm (panel I) and 365 nm(panel II).
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HPLC/MS analysis 4.4.2
Further chromatographic analysis of the aqueous Doash extract (2% w/v) was carried out 
using HPLC/MS. The chromatogram indicated that the highest mass peak was detected at 
a retention time of 35 minutes. (Table 4.4) (Figure 4.3). These experiments were done by 
colleagues in the University of Surrey (Professor Clifford’s laboratory).
Table 4.4 HPLC/MS analysis of aqueous Doash extract (2% w/v).
Retention Time 
((min Parent Ion m/z MS2 base peak m/z MS3 base peak m/z
4.64 330.8
15.5 324.9
19.5 593.1 473.0 353.0
24.0 433.1 322.9 220.9
33.8 358.9 161.0
35.5 460.9 285.0
40.1 444.9 269.0
43.2 802.9 564.3
47.3 431.1 260.9 187.0
The mass spectral data for the main peaks are presented in this table.
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Antimutagenic activity of the aqueous Doash fractions 4.4.3
As shown in (Table 4.5) the Doash aqueous extracts inhibited the mutagenic 
activity of all mutagens employed in the current study. Similarly, all fractions displayed 
antimutagenic activity, but to different degrees. The results show that the mutagenic 
activity of IQ was significantly decreased by all Doash fractions, and in particular fraction 
No. 5. The same fraction also was the most potent to suppress the mutagenicity of 
benzo(a) pyrene. The mutagenicity of nitrosopiperidine was noticeably reduced by Doash 
fraction No 4. The results also demonstrated that the Doash extract and all fractions 
antagonised the mutagenicity of the direct-acting mutagen MNNG, fractions No.5 and No. 
6 being the most effective (Figure 4.4).
103
Table 4.5 The antimutagenic activity of Doash fractions against four model
carcinogens
Doash tea 
Fractions
TA 98 TA 100 TA 1530
IQ
(lOng/plate)
Benzo(a)pyren
e
(25pl/plate)
MNNG
(Ipg/plate
(
Nitrosopiperidine
(4mg/plate)
--- 1982±9 395±5 867±8 339=38
Doash extract 559±10 145±6 338±7 1523=9
Fraction 1 599±8 171±6 297±5 116=39
Fraction 2 611±6 169±4 2713=6 176=38
Fraction 3 515±7 206±5 2333=5 153=34
Fraction 4 451±6 230±3 191=39 86=36
Fraction 5 204±4 110±8 108=33 120=38
Fraction 6 246±4 156±11 98=32 128=36
Fraction 7 437±6 200±5 1183=6 171±7
Fraction 8 577±7 249±6 139=35 181=35
Fraction 9 605±5 171±7 1423=7 249=34
Fraction 10 677±9 203±6 1393=4 177=38
Fraction 11 712±6 216±8 188=310 2053=4
Fraction 12 691±3 175±6 145=35 229=37
The mutagenicity assay was performed using Salmonella typhimirium strains TA 98, 
TAIOO and TA 1530 in the Ames test. Doash extract fractions (500ul/plate) were 
incorporated into an hepatic S9 activation system derived from Aroclor 1254-induced rats 
(10%v/v), or from isoniazid-treated rats (25%v/v) in the case of nitrosopiperidine. The 
spontaneous reversion rates of 24±1, 74±1, 89±1 and 19±2 for IQ, benzo(a)pyrene, 
MNNG, and N-nitrosopiperidine respectively, have already been subtracted. Results are 
presented as mean ±SD of triplicates.
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Figure 4.4 Antimutagenic activity of the Doash fractions against four model 
carcinogens IQ, benzo (a) pyrene (Bp), MNNG and nitrosopiperidine (NP). The
mutagenicity assay was perfonned using Salmonella typhimirium TA 98, TAIOO and TA 
1530 in the Ames test. Doash extract fractions (500ul/plate) were incorporated into an 
hepatic S9 activation system derived from Aroclor 1254-induced rats (10%v/v), or from 
isoniazid-treated rats (25%v/v), in the case of nitrosopiperidine. The spontaneous reversion 
rates of 24±1, 74±1, 89±1 and 19±2 for IQ, benzo(a)pyrene, MNNG and N- 
nitrosopiperidine respectively, had already been subtracted. Results are presented as mean 
±SD of triplicates.
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.Antimutagenic activity of the solvents against IQ and MNNG 4.4.4
This study was conducted to evaluate the effect of solvents used (A, B and A+B), and the 
mutagens with IQ (indirect acting mutagen) and MNNG( direct acting mutagen). Results 
obtained showed that there was a significant difference in the antimutagenic effect of 
solvents A, B, A+B as compared with positive control IQ when solvent B exert effect as 
compared with MNNG.
Table 4.6 The effect of solvents against IQ and MNNG
Anti­
mutagenic
effect
(IQ (lOng/plate (MNNG (Ipg/plate
IQ))
+ve
Solvent
A
Solvent
B
A+B MNNG
ve+
Solvent
A
Solvent
B
A+B
Mean + SD 1799+5
*
1604+8
*
1333+5
*
1400+2 605+5 588+8
*
456+5 499+2
This study was carried out using Salmonella typhimurium strain TA 98 (IQ) into and TA 
100 (MNNG).Solvents were incorporated into an hepatic S9 activation system derived 
from Aroclor 1254-induced rats (10%v/v) in case of IQ mutagen. All results were presented 
in triplicate. The spontaneous reversion rate for IQ and MNNG, 41+2 and 105+3 
respectively, had been substracted. *P < 0.05
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Inhibition of hepatic methoxyresorufin O-demthylase by Doash 4.4.5 
.fractions of aqueous extracts
Incorporation of aqueous Doash extracts of the various fractions resulted in
inhibition of the 0-demethyIation of methoxyresorufin (Figure 4.5). Statistical anlysis 
revealed that fractions 4,6 and 10 showed a significant inhibitory effect on the activity of 
methoxyresorufib 0-demethylase (*P < 0.01), while the other fractions showed less 
inhibitory effect (*P < 0.05) compared with control.
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Figure 4.5 Inhibitory effects of Doash aqueous extract fractions on the activity of 
methoxyresorufin O-demethylase. The assay was carried out in the presence of lOOpl of 
Doash tea (D) (2 % w/v) and isolated Doash tea fractions (F) employing microsomal 
suspension (25% w/v) from rats, pretreated with Aroclor 1254-induced. Results are
presented as mean ±SD of triplicates. *P < 0.05; *P < 0.01
108
Discussion 4.5
The results indicated that the Doash aqueous extract, as already shown in Chapter 3, 
decreased the in vitro S9-mediated mutagenicity of IQ, benzo(a) pyrene, nitrosopiperidine 
and MNNG. Similarly, the various fractions suppressed mutagenicity, but to a different 
extent. This antimutagenecity was due to the total solid content of each fraction. It was 
found that fraction No.5 was the most potent inhibitor of mutagenicity for all mutagens 
used, except nitrosopiperidine, for which fraction No.4 was the most potent. Also, the 
highest concentration of total solids occurred in fraction No.5, followed by No.4.
Fraction No.4, despite having a lower amount of total solids than fraction No.5, was the 
most effective antimutagen against N-nitrosopiperidine. However, it appeared that fraction 
No.6, as well as fraction No.5, inhibited the direct mutagenic activity of MNNG. It is 
probable that the effect of fraction No.5 is due particularly to the strong antimutagenic 
activity of Doash extract. Overall, these studies suggest that the major antimutagenic 
component present in Doash tea is found in fraction No.5, followed by fraction No.4.
The aroma, flavour and pharmaceutical value of cultivated organo (Origanum vulgare 
L.) is a consequence of its essential oil that consists mostly of monoterpenes and 
sesquiterpenes (Crocoll C et al., 2010). HPLC/MS analysis of aqueous Doash extract at the 
University of Surrey suggested that the major component identified was also terpenes. A 
previous study conducted by Vagi et al., (2005), revealed that the characteristic compounds 
of Origanum majorana are: y terpinene, linalool, a  terpineal, a  terpinolene, a  terpinene, p- 
Caryophllene and Spathulenol at 7.18 min., 9.7 min., 11.59, 8.77 min., 7.18 min., 14.44 
min. and 37.21 min. respectively. From this study we can deduce that the antimutagenic 
activity of Doash extract may also be attributed to its high content of terpenes, which
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inhibit the model carcinogens used in this study. Therefore antimutagenic effect of Doash 
extract against IQ and PhIP is attributed to its antioxidant activity .
The most important cytochrome P450 enzymes catalysing the bioactivation of benzo(a) 
pyrene and IQ, are CYPlAl and CYP1A2, respectively (Yamazoe et al., 1984; Battula et 
al., 1987). It is likely, therefore, that the observed inhibitory effect of Doash tea fractions, 
resulted from their ability to reduce the cytochrome P-450- dependent monoxgenase, 
catalysing the metabolic activation of the promutagens used in this study. Such a 
mechanism appears to be consistent with the present study, which showed that when 
included into an incubation system in vitro, fraction Nos. 4, 5 and 8 from the Doash tea 
infusion inhibited the dealkylation of methoxyresorufin, and this reaction is selectively 
catalysed by the cytochrome CYP1A2 (Namkung et al., 1988). Alongside the Doash tea 
infusion, fraction No.5 displayed a very marked inhibition towards this activity, when 
compared with the other fractions. The activity of methoxyresorufin O-demethylase was 
also selectively inhibited by fraction Nos.4 and 8, but to lesser decrease compared with 
fraction No.5. Since the antimutagenic effects of Doash tea extracts and fraction No.5 
towards IQ are the same, it is likely that fraction No.5 contributed extensively to the 
antimutagenic potential of Doash tea by modulating CYPlA2-mediated bioactivation. In 
addition, it was found that the solvents A,B and A+B showed some antimutagenic effects, 
but these were much lower than the fractions themselves, when tested with IQ and MNNG. 
This explained the good correlation between the antimutagenic potential of the Doash 
reactions and fraction No.5, which was rich in solid content.
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Conclusion 4.6
In summary, the results of the present study demonstrate that the Doash tea components 
have the ability to reduce the in vitro mutagencity of several promutagens employed in this 
study. Fraction No.5 (with the highest content of solid), was the most potent inhibitor of 
the mutagenicity of all promutagens tested. When present during microsomal metabolism, 
the antimutagenic effect of Doash tea extract, and its various fractions, was pronounced, 
indicating that the metabolism of CYP1A2 is likely to be inhibited.
I l l
CHAPTER 5 
Modulation of the rat hepatic 
carcinogen-metabolizing enzyme 
systems by Doash
112
Introduction 5.1
Since human cancer ocurrence is linked to dietary habits and lifestyle, as clearly 
indicated by mounting evidence, it becomes of great importance to search for a simple diet, 
a common beverage or a herbal remedy to provide a means of protection against cancer. 
This approach goes hand-in-hand with the increasing attention that has recently focussed 
on the use of cancer chemopreventive agents for individuals at high risk of neoplastic 
development (Byers et al, 2002).
Many studies have demonstrated that Origanum majorana is a potent antioxidant 
with antimicrobial activities (Gortzi et al., 2007 and Faleiro et al., 2005). Another study 
suggested that O. majorana displayed anti-hepatoma activity in five human liver-cancer 
cell lines, i.e HepG2/C3A, SK-HEP-1, HA22T/VGH, Hep3B and PLC/PRF/5 (Lin et al., 
2002). The anti-genotoxicity of Origanum majorana was reported by (El-Ashmawy et al., 
2005), who verified the ability of O. majorana extracts to reduce the micronucleus number 
of aberrant cells in rats and different kinds of chromosomal aberrations which were induced 
by lead toxicity in mice.
The present study was undertaken in an attempt to assess whether Doash tea 
modulates the cytochrome P450 mixed function oxidase system, as well as phase II 
enzymes, by exposing to rats to a concentration of Doash tea, similar to that consumed by 
humans. The impact of these changes on the bioactivation model of carcinogens was also 
investigated.
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Methods 5.2
5.2.1 Animal pre-treatment
Male Wistar albino rats (120-150 g) were purchased from the animal house in the King 
Fahad Research Center, King Abdulaziz University, Jeddah, KSA. Thereafter, the rats 
were randomly divided into two groups, comprising 5 animals each. One group served as 
control, whereas the other was maintained on aqueous Doash extract (2% w/v) as its sole 
drinking liquid for four weeks. The animals were then killed, livers excised and S9 was 
prepared from individual animals as previously described (Section 2.2.5), with the 
exception that the cytosol was recentrifuged at 105 OOOg for 1 hour to remove any 
microsomal contamination. Preparation of Doash extracts has been described in Section 
2.2.2.
5.2.2 Enzyme assays
The protein levels of the hepatic S9 fraction, microsomes and cytosol were measured 
by the Lowry procedure (1951), using bovine serum albumin as a standard. The following 
enzyme assays were carried out using isolated microsomes: Ethoxyresorufin 0-deethylase 
(Burke and Mayer, 1974), methoxyresorufin O-demethylase (Bruke and Mayer, 1983), 
pentoxyresorufin 0-depentylase (Lubet et al., 1985), p-nitrophenol hydroxylase (Koop et 
al., 1989), erythromycin N-demethylase (Wrighton et al., 1985), epoxide hydrolase using 
benzo(a)pyrene-4,5-oxide as substrate (Dansette et al., 1979) and UDP-
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glucuronosyltransferase, employing 2-aminophenol as a substrate, (Burchell, 1974). In 
addition to these microsomal assays, the following enzyme activities were performed on 
the cytosolic fraction: Glutathione S-transferase using CDNB and DCNB as substrates 
(Habig et al., 1974), and sulphotransferase using 2-naphthol as a substrate (Sekura et al., 
1981). All these assays are described in detail in Chapter 2.
5.2.3 Immunobloting studies
Immunoblot analysis of electrophoretically separated microsomal proteins on sodium 
dodecyl sulphate polyacrylamide gels was performed using antibodies to rat CY PlA l, 
CYP1A2, CYP2B, CYP2E1 and CYP3A, according to the method of (Laemmli, 1970) and 
then electrotransferred to nitrocellulose membrane by the general procedure. Antibodies 
were then used to identify specific polypeptides by probing the membrane (Towbin et al., 
1979), as described in Section 2.2.8. All blots were scanned on a densitometer/image 
analyser (SynGene, GeneTools - File version: 3.07.03).
Mutagenicity assays 5.2.4
The effect of treatment with an aqueous Doash extract on the activation of model 
mutagens was determined using the Ames Salmonella test (Maron and Ames, 1983). The 
activation system was prepared from control (pooled) and Doash-treated animals (pooled). 
All mutagens (IQ 10 ng, PhIP lOug, benzo[a]pyreme 25ug, dimethylbenz[a]anthracene 
50ug, nitrosopiperidine 4mg and N- Nitrosopyrolidine 6 mg) were dissolved in DMSO, so 
that the final concentration remained below 100 ul per incubation.
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Results 5.3
Modification of cytochrome P450 -dependent activities by 5.3.1 
Doash tea
Adminstration of 2% Doash tea infusion as the sole source of drinking for four weeks 
did not affect the animal body weight gain (Figure 5.1).
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Figure 5.1 Effect of Doash extract on the body weight in rats. Two groups of 5 rats 
each were exposed to Doash extract (2%w/v), whereas controls were maintained on water 
alone. These results are presented as mean and SD.
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As illustrated in Table 5.1, treatment of rats with Doash tea impaired the 0-dealkylations of 
methoxy- and ethoxy- resorufin. Similarly, there was a significant decrease in the O- 
depentylation of pentoxyresorufin together with the déméthylation of methoxyresorufin 
whereas only a significant decrease in the hydroxylation of p-nitrophenol was detetrmined. 
In contrast, there was a significant elevation of erythromycin N-demethylase in add of 
Doash extract.
Table 5.1 Effect of Doash tea extract administration on rat hepatic mixed 
function oxidase activities.
Parameter 
(Liver weight/body weight)
100 X
Methoxyresorufin O-demethylase 
( pmol/min /mg protein)
Pentoxyresorufin O-depentylase 
(pmol/min /mg protein)
Control Doash aqueous 
extract
4.7±1
±3 38
4±1
±1 4.8
12.8±2
* * 2± 0.01
Ethoxyresorufin O-deethylase 
(pmol/min /mg protein) 24±3 11±3
p-NitrophenoI hydroxylase 
(pmol/min /mg protein) ±0.91 30 *±0.93 20
Erythromycin N-demethylase 
(pmol/min/ mg protein)
±0.89 29 *±0.91 39
Two groups of rats was employed; one group treated with aqueous Doash extract (2% w/v) 
as their sole drinking fluid, and the other group were maintained with water for four weeks. 
Results are presented as mean ± SD for five animals. *P < 0.05 
? < 0.01** ,
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Immunoblot analysis of P-450 enzymes 5.3.2
Western blot analysis was employed to detennine whether the observed increase in 
enzyme activities was also accompanied by the elevation of enzyme apoprotein levels. 
Hepatic microsomes from Doash tea-treated rats were probed with polyclonal antibodies to 
rat CYPlA l, CYP2B and CYP2E1 and monoclonal antibodies to rat CYP1A2 and CYP3A. 
Consumption of Doash extract revealed a decrease in the apoprotein levels of CYP1A2 and 
CYPlAl. (Figures 5.2 and 5.3)
Probing with antibodies to CYP2B demonstrated a decrease in CYP2B apoprotein levels 
(Figure 5.4). A small decrease in the level of CYP2E1 apoprotein level was observed, 
following the treatment with Doash tea (Figure 5.5). Treatment with Doash tea also 
influenced a decrease in the CYP3A levels (Figure 5.6 ). Image-Pro Plus 6.0 software 
(Media cybernetics, USA) was used to edit best fit equalization to remove the faint spots.
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Figure 5.2 Effect of treatm ent with Doash on hepatic microsomal CYPl A2 levels in 
the liver of rats. Microsomal proteins (20 pg) were resolved by electrophoresis in a 10% 
SDS-polyacrylamide gel and transferred electrophoretically to nitrocellulose. The 
immunoblot was conducted with mouse monoclonal [ dl5(16VII F10FI2)] to CYP1A2 
(diluted 1: 10000), followed by peroxidase-linked rabbit polyclonal to anti-mouse IGg 
whole molecule (diluted 1:10000). Control (C); Doash tea (Do) and Aroclor 1254 (Ar)
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which are used as a positive control. The values in italics show optical density percentage 
of each band, relative to control.
79.8 100 516
Figure 5.3 Effect of treatment with Doash on hepatic microsomal CYPlAl levels in 
the liver of rats. Microsomal protein (20 pg) was resolved by electrophoresis in a 10% 
SDS-polyacrylamide gel and transferred electrophoretically to nitrocellulose. The 
immunoblot was conducted with Rabbit polyclonal to CYPlAl (diluted 1:10000), followed 
by peroxidase-linked Goat polyclonal to ant-rabbit IGg- (diluted 1:3000). Control (C) : 
Doash tea (D) and Aroclor 1254 (Ar)which are used as a positive control. The values in 
italics show optical density percentage of each band, relative to control
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Figure 5.4 Effect of treatment with Doash on hepatic microsomal CYP2B levels in 
the liver of rats. Microsomal protein (80 pg) was resolved by electrophoresis in a 10% 
SDS-polyacrylamide gel and transferred electrophoretically to nitrocellulose. The 
immunoblot was conducted with Mouse monoclonal [b/e3(9.14)] to CYP2B (diluted 
1:10000), followed by peroxidase-linked rabbit polyclonal anti-mouse (diluted 1:2000). 
Control (C) : Doash tea (D) and Dexamethasone (Dx) which are used as a positive control. 
The values in italics show optical density percentage of each band, relative to control.
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Figure 5.5 Effect of treatment with Doash on hepatic microsomal CYP2E1 levels in 
the liver of rats. Microsomal protein (80 pg) was resolved by electrophoresis in a 10% 
SDS-polyacrylamide gel and transferred electrophoretieally to nitrocellulose. The 
immunoblot was conducted with rabbit polyclonal to CYP2E1 (diluted 1:5000 ), followed 
by peroxidase-linked goat polyclonal anti-rabbit IGg (diluted 1:2000). Control (C) : Doash 
tea (D) and Isoniazid (Is) which are used as a positive control. The values in italics show 
optical density percentage of each band, relative to control.
100 145
Dx
Do
Figure 5.6 Effect of treatment with Doash on hepatic microsomal CYF3A levels in the 
liver of rats. Microsomal protein (40 pg) was resolved by electrophoresis in a 10% SDS- 
polyacrylamide gel and transferred electrophoretically to nitrocellulose. The immunoblot 
was conducted with sheep monoclonal to CYP3A (diluted 1:20000), followed by 
peroxidase-linked rabbit anti-sheep) (diluted 1:5000). Control (C) : Doash tea (Do) and 
Dexamethasone (Dx) which are used as a positive eontrol. The values in italics show 
optical density percentage of each band, relative to control.
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Effect of Doash tea treatment on rat hepatic conjugation 5.3.3 
enzyme activités
The effect of Doash tea administration on hepatic phase II conjugating enzymes is 
shown in Table 5.2. Glutathione S-transferase activity, determined by using CDNB and 
DCNB as substrates, was not significantly modulated following treatment with Doash tea. 
No significant change was recorded in the activity of sulphotransferase, which was 
monitored using 2-naphthoI substrate on glucuronosyl transferase when measured in the 
presence of 2-aminophenoI. On the other hand, Doash tea influences a caused rise in the 
activity of epoxide hydrolase, utilizing benzo(a)pyrene-4,5-oxide as a substrate (Table 5.2).
.Table 5.2 Effect of Doash aqueous extract on rat hepatic phase II enzyme activities 
Parameter Control Doash extract
Gtaci.roiio.yl O im rf.r... „ ,  ;  ;
(pmoL/mm per mg protein)
Glutathione S-transferase DCNB
(nmole/min per mg protein)
Glutathione S-transferaseCDNB
((umohmin per mg protein
33.3±6 35.4±5
16.5±I 0.89 16.44=
Sulphotransferase ^ 0.14 0.67±
((nmol/mm per mg protein
Two groups of rats was employed; one group treated with aqueous Doash extract (2% w/v) 
as their sole drinking fluid, and the other group were maintained with water for four weeks. 
.Results are presented as mean ± SD for five animals
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Effect of Doash tea treatment on the bioactivation of 
chemical carcinogens
5.3.4
a) Heterocyclic amines)
Hepatic S9 preparations from Doash tea-treated rats suppressed mutagenic activity of 
carcinogen IQ at the concentrations employed (Figure 5.7). A similar picture emerged 
with another heterocyclic amine, PhIP (Figure 5.8).
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Figure 5.7 Bioactivation of IQ hepatic preparations from Doash-treated rats. The mutagenic 
activity o f IQ against TA98 was determined employed S9 preparations from control (pooled) and 
Doash-treated animals (pooled) as an activation system. Positive control (10 ng o f IQ) o f  1780 ±5 
supplemented on hepatic S9 preparation (10% v/v) from Aroclor 1254 induced rats. The 
spontaneous reversion rate o f 31 4  1 has already been subtracted. Results are presented as means ±  
SD of triplicates/plate.
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Figure 5.8 Bioactivation of PhIP hepatic preparations from Doash-treated rats. The
mutagenic activity of PhIP against TA98 was determined employed S9 preparations from control 
(pooled) and Doash-treated animals (pooled) as an activation system. Positive control (10 ng of 
PhIP) o f  659 ±3 supplemented on hepatic S9 preparation (10% v/v) from Aroclor 1254 induced 
rats. The spontaneous reversion rate o f 35 ± 3 has already been subtracted. Results are presented as 
means ± SD of triplicate plates.
b) Polvcvclic aromatic hvdrocarbons)
Hepatic S9 preparations from Doash-treated rats were less effective in bioactivating 
benzo(a)pyrene, compared with control (Figure 5.9), and a similar picture was obtained 
with 7,12 dimethylbenzo(a)anthracene at different concentration in the Ames test (Figure 
5.10).
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Figure 5.9 Bioactivation of benzo(a)pyrene by hepatic preparations from Doash- 
treated rats. The mutagenic activity of benzo(a)pyrene against TA 100 was determined 
employed S9 preparations from control (pooled) and Doash-treated animals (pooled) as an 
activation systems. Positive control (25 ug of BP) of 344 ±7 supplemented by hepatic S9 
preparation (10% v/v) from Aroclor 1254 induced rats. The spontaneous reversion rate of 
104 4 3 has already been subtracted. Results are presented as means ± SD of triplicate 
plates.
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Figure 5.10 Bioactivation of 7,12 dimethyl benzo(a)anthracene by hepatic 
preparations from Doash-treated rats. The mutagenic activity of 7,12 dimethyl 
benzo(a)anthracene against TA 100 was detennined using S9 preprations from control 
(pooled) and Doash-treated animals (pooled) as an activation system. Positive control (25 
ug ) of 525 ±5 supplemented by hepatic S9 preparation (10% v/v) from Aroclor 1254 
induced rats. The spontaneous reversion rate of 115 ± 4 had already been subtracted. 
Results are presented as means ± SD of triplicate plates.
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(c) Nitrosoamines
The mutagenic activity of N-nitrosopiperidine was lower in the Doash-treated hepatic 
S9 when compared with controls (Figure 5.11), and a similar picture emerged in the case 
of N- nitrosopyrrolidine (Figure 5. 12).
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Figure 5.11 Bioactivation of N-nitrosopiperidine by hepatic preparations from 
Doash-treated rats. The mutagenic activity of nitrosopiperidine against TA 1530 was 
detennined using S9 preparations from control (pooled) and Doash-treated animals 
(pooled) as an activation systems. Positive control (4 mg of NP) of 400 ±8 supplemented 
by hepatic S9 preparation (25% v/v) from Isoniazid induced rats. The spontaneous 
reversion rate of 14 ± 2 had already been subtracted. Results are presented as means ± SD 
of triplicates.
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Figure 5.12 Bioactivation of N-nitrosopyrroldine by hepatic preparations from 
Doash-treated rats. The mutagenic activity of nitrosopyrroldine against TA 1530 was 
detennined using S9 preparations from control (pooled) and Doash-treated animals 
(pooled) as an activation system. Positive control (4 mg of NP) of 320 ±4 supplemented by 
hepatic S9 preparation (25% v/v) from Isoniazid induced rats. The spontaneous reversion 
rate of 12 ± 5 had already been subtracted. Results are presented as means ± SD of 
triplicates.
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Discussion 5.4
Several dietary constituents have been shown to modulate the process of 
carcinogenesis, and this was investigated in many epidemiological and experimental 
studies in a variety of animal models. This modulatory effect of diet was involve changes 
in the enzyme systems that catalyse the metabolic activation or deactivation of chemical 
carcinogens.
The results described in Chapter 3 indicate that Doash tea suppresses the mutagenicity 
of chemical carcinogens, which were initially assigned to a decrease in cytochrome P450- 
mediated bioactivation of the model carcinogens, and may also contribute to the 
antimutagenic potential of Doash tea. However, the in vitro findings must be shown to be 
operative in vivo.
The present investigation was concerned with the effects of Doash tea administration on 
hepatic xenobiotic-metabolising cytochrome P450 enzymes and phase II conjugation 
systems. Significant changes in the activities and levels of individual cytochrome P450 
enzymes, were monitored by the use of diagnostic probes, and immunologically utilizing 
polyclonal and monoclonal antibodies. In the present study, treatment with Doash tea 
significantly decreased the 0-demethylation of methoxyresorufin, which is a selective 
probe for CYPIA2 activity (Burke and Mayer, 1983). This was also confirmed by the 
immunoblot analysis, where a decrease in the levels of CYPIA2 apoprotein was recorded. 
The same treatment with Doash tea to inhibition of 0-deethylation of the ethoxyresorufin,
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which operates as a diagnostic probe for CYPlAl activity, although it is also metabolised 
by CYPlAl (Philipson et ah, 1984 and Namkung et ak, 1988). Similarly, administration of 
Doash tea caused a marked decrease in the 0-depentylation of pentoxyresorufin, which is 
selectively catalysed by the CYP2B sub family (Lubet et al, 1985. This treatment 
significant decreased the hydroxylation of p-nitrophenol, which is catalysed by CYP2E 
(Koope/fl/., 1989).
These results suggest that treatment of rats with Doash tea extracts caused a decrease in 
hepatic cytochrome P450 proteins, such as CYP2B, CYP2E1 and CYPl A, the latter P450 
sub-family being closely associated with inhibiting bioactivation of chemical carcinogens. 
We may therefore conclude that the concentration of Doash extract achieved in the liver 
after a 4 week administration period is sufficient to inhibit the CYP2B, CYP2E1 and 
CYPl A enzymes monitored in the present study.
Potential studies in animal models indicated that chemical carcinogenesis and 
mutagenesis may be inhibited by various naturally-occurring chemicals, including 
polyphenolic compounds (Okuda et al., 1984; San and Chan, 1987; Tanaka et al., 1993). 
This hypothesis has been evaluated by investigating the mutagenicity of the food 
carcinogens IQ and PhIP, whose activation is catalysed predominantly by CYP1A2 ( Kato 
et a l, 1983; Abu-Shakra et 1986 and Turesky. 2002). In fact, hepatic preparations 
from Doash tea treated-rats decreased the activation of IQ and PhIP, commensurate with a 
decrease in CYPlAl and CYP1A2 levels. The polycyclic aromatic hydrocarbons, 
(benzo(a)pyrene and 7,12 dimethylbenzanthracene), are both promutagens. The S9 hepatic 
preparation requires bioactivation from Doash tea-treated rats and was also in 
correspondence to the decrease in CYPlAl and CYP2B level.
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Finally, the mutagenicity of nitrosopiperidine and nitrosopyrrolidine, nitrosoamines 
selectively activated by CYP2E, was decreased by the hepatic preparations from Doash- 
tea-treated rats.
My results suggest that Doash tea may possess anti-carcinogenic potential, by directing 
the metabolism of the chemical carcinogens in such a way as to favour their detoxification. 
The present study was therefore also undertaken to establish whether the decrease in 
mixed-function oxidase activities and carcinogen activation is accompanied by changes in 
the phase 11 enzyme. In this respect, Doash extract doesn’t modulate epoxide hydrolase 
activity in macrosomal rats, in addition, glutathione conjugation is probably the most 
effective metabolic pathway for eliminating reactive intermediates, a process which is 
catalysed by glutathione S-transferase (Sohn et al., 1994). Such a mechanism of action, 
however, appeared unlikely, since the measured activity of glutathione S-transferase using 
a CDNB and DCNB substrate was unaffected by the treatment with Doash extracts. The 
same treatment with Doash also failed to modulate sulphotransferase conjugation in rat 
liver. Similarly, after pre-treatment of rats with Doash tea extract, there was no observable 
increase in the glucuronidation of 2-aminophenol activity.
However, there was no marked increase in observed levels of the enzyme activity, 
following the Doash tea administration. Doash tea may also exert its anticarcinogenic 
potential by stimulating the enzyme system that deactivates reactive oxygen species.
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Conclusion 5.5
The present study has shown that Doash tea has the potential to suppress the activity of 
cytochrome enzymes involved in the bioactivation of chemical carcinogen and, 
consequently, may display chemopreventive activity.
Chapter 1
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CHAPTER 6
Influence of aqueous Doash extract ou 
urinary mutagenicity in rats exposed to 
heterocyclic amines
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Introduction 6.1
A new strategy involving anti-neoplastic and free radical scavenging properties has 
enabled us to investigate the potential of various phytochemicals, in order to detect anti­
tumor and free radical scavenging activities (Ramar et ah, 2006). Tea is the most 
extensively consumed beverage worldwide. It possesses anticarcinogenic activity in 
animal models of cancer (Wang et ah, 1992, 1994; Gupta et aL, 2001; Li et a l, 2002). 
McArdle and colleagues (1999) revealed that exposure to green, black or decaffeinated 
black tea for one month decreased the excretion of direct and indirect mutagens in the urine 
of rats that had been treated with a single oral dose of the heterocyclic amine 2-amino-3- 
methylimidazo[4,5-f] quinoline (IQ). Embola et al (2001) reported that green tea had a 
potential effect to detoxify IQ when administered to rats for six weeks, so as to favour 
detoxification pathways, investigating the tea-mediated changes in urinary mutagens. 
Moreover, it was demonstrated that black tea suppresses the excretion of mutagens in the 
urine of rats, when administered even for a single day, prior to a single dose of IQ (Yoxall 
et al, 2004). This effect was linked to enhancement of hepatic CYP1A2 activity, which is 
responsible for the metabolism of IQ (Turesky, 2002). These results collectively indicate 
that widely consumed tea beverages, have the potential to influence carcinogen 
metabolism.
In the present study, the potential of Doash tea to influence carcinogen metabolism was 
investigated indierctly, using heterocyclic amines as model mutagens.
IQ and PhIP have been used as model mutagens for the following reasons:
1- IQ and PhIP are carcinogens present in cooked food (Skog and Jagerstad, 1998).
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2 - IQ is a very potent mutagen in the Ames test (Sugimura et aL, 1993).
Materials and Methods 6.2 
Materials 6.2.1
The Doash plant was purchased locally and stored in a refrigerator. Male Wistar 
albino rats (120-150 g) were obtained from the King Fahad Medical Research Centre, and 
were used in all studies. The activation system (Aroclor 1254-induced S9) was purchased 
from the University of Surrey. Doash inftisions (2% w/v) were prepared by adding boiling 
water (100 ml) to the Doash plant (2g), in a pre-warmed thermos flask, leaving it to stand 
for 10 min, with an inversion every 30 sec., and then filtering it through 0.2 pm filter 
papers. Similarly, green tea infusions (2.5% w/v) were prepared by adding boiling water 
(100 ml) to green tea 2.5 g (Gun powder), in a pre-warmed thermos flask, leaving it to 
stand for 10 min with an inversion every 30 sec., and then filtering it through cotton wool 
to obtain a 2.5 % (w/v) tea infusion.
Methods 6.2.2
A preliminary study was first carried out to meet the following objectives: (i) to 
establish whether urinary excretion of mutagens is dose-dependent, following 
administration of IQ and PhIP; (ii) to establish the time profile of urinary mutagen 
excretions, following IQ and PhIP administration.
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Carcinogen ( lOI administration
Male albino rats (150 g) were divided into 5 groups comprising 3 animals each, 
one of which served as the control group. The others were given by gastric intubation with 
a single dose of 1, 3, 5 or 10 mg/kg body weight of IQ, which had been dissolved in com 
oil by gastric incubation; urine was collected daily for three days and stored at -80°C, until 
analysis.
Carcinogen PhIP adminstriation
Male rats (150g) were divided into 5 groups comprising 3 animals each, one of 
which served as the control group. The others were given by gastric intubation with a 
single dose of 1,5, 10 or 20 mg/kg body weight of PhIP, which had been dissolved in com 
oil; the urine of the rats was collected daily for three days and stored at -80°C, until 
analysis.
To assess the effect of Doash extracts on urinary mutagenicity, four groups were 
used, comprising five rats each. The first group served as a control, and the second 
(positive control) group received a green tea extract (2.5% w/v) as the sole drinking liquid. 
The other two groups were maintained on (2% w/v) aqueous Doash extracts as their sole 
source of liquid for either one day, or one month. At the end of the treatment periods (1 
day or 1 month), all groups received a single dose of IQ (5 mg/kg) or PhIP (5 mg/kg) by 
gastric intubation. Urine was collected daily for three days. Urine samples were 
centrifuged at 2000g for 10 min and the supematant was filtered, by passing through 0.2 
pm filter papers, and stored at -80°C until use. Mutagenic activity was assessed using the 
Ames mutagenicity assay (Maron and Ames, 1983), in the presence and absence of a 10%
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(v/v) activation system, which had been derived from Aroclor 1254-induced rats, and 
employing a strain of Salmonella typhimurium YG1024, as described in section (2.2.6.8)
Results 6.3
Results obtained showed that Doash tea had no influence body weight in both 
studies. (Figures 6.1 and 6.2).
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Figure 6.1 Effect of treatment with Doash or green tea on animal body weight. The
animals were maintained on either Doash extract (2% w/v) for a period of one day (short­
term) or one month (long-term), or on green tea for one month 
(long-term). Body weight was measured twice a week. Results are presented as means ± SD.
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Figure 6.2 Effect of treatment with Doash or green tea on animal body weight. The
animals were maintained on either Doash extract (2% w/v) for one day (short-term) or one 
month (long-term), or on green tea for one month (long-term). Body weight was measured 
twice a week. Results are presented as means ± SD.
Rats were treated with different doses of IQ (1, 3, 5, and 10 mg/kg), or PhIP (1,5, 10 
and 20 mg/kg), to establish suitable dose which gives a good mutagenic effect, and 
which may be used in subsequent studies. The chosen dosage was 5 mg/kg for both 
heterocyclic amines (Figures 6.3 and 6.4
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Figure 6.3 (a,b,c) Effect of different IQ doses on urinary mutagenicity. Rats were 
treated orally with a single dose of IQ (0, 1 ,3 ,5 , 10 mg/kg). Urine was collected daily for 
three days (a after 24h, b after 48h and c after 72h) and mutagenicity was detennined using 
the Ames test (YG1024), in the presence of an Aroclor 1254-indueed activation system 
(10%w/v). Results are presented as means ± SD of triplicates. The spontaneous reversion 
rate of 34±4 has already been subtracted.
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Figure 6.4 (a.b,c) Effect of different PhIP doses on urinary mutagenicity. Rats were 
treated orally with a single dose of PhIP (0, 1, 5, 10, 20 mg/kg). Urine was collected 
daily for three days (a after 24h, b after 48h and c after 72h) and mutagenicity was 
detemiined using the Ames test (YG1024), in the presence of an Aroclor 1254-induced 
activation system (10%w/v). Results are presented as means ± SD of triplicates. The 
Spontaneous reversion rates 30±2 had already been subtracted.
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Results revealed that rats treated with Doash tea and then given a single dose of the 
heterocyclic amines, whether for one day (short-term) or for one month (long-term), 
showed a statistically significant decrease in their excretion of indirect mutagens (IQ or 
PhIP), (Figures 6.5 and 6.6). Concurrently, the positive control group of rats who had been 
administered green tea for one month (long-term), showed a significant mutagenic 
decrease, in comparison with the control group (Figures 6.5 and 6.6). Following treatment 
of the rats with a single oral dose of IQ or PhIP, the highest mutagenic activity determined 
in the presence of an activation system was excreted in the urine after 24h, with much 
lower levels of mutagenicity being excreted during subsequent elimination from the body 
(Figures 6. 5 and 6.6).
No mutagenicity was observed in the absence of an activation system i.e. direct- 
acting mutagenicity using (IQ and PhIP). Statistical analysis revealed that, in comparison 
with the control group, the aqueous Doash extract significantly reduced the mutagenicity 
using IQ and PhIP after 24 hours as.
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Figure 6.5 : Effect of Doash extract on the excretion of indirect mutagen in rats 
receiving IQ. Rats were exposed to either Doash extract (2% w/v) or green tea (2.5% 
w/v), for one day (short- term or one month (long-term), whereas controls were maintained 
on water. At the end of the treatment period, all animals received a single oral dose of IQ 
(5mg/kg). Mutagenic activity was deteraiined using a strain of Salmonella typhimurium 
YG1024, in the presence of an activation system containing hepatic S9 (10%v/v) isolated 
from Aroclor 1254-induced rats. Results are presented as mean ± SD and were corrected 
for volume of urine excreted. Each analysis was conducted in triplicate. *P < 0.001 
represents comparison between the groups treated with tea and control.
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Figure 6.6 Effect of Doash extract on the excretion of indirect mutagen in rats 
receiving PhIP. Rats were exposed to either Doash extract (2% w/v) or green tea (2.5% 
w/v), for one day (short-term or one month long-term), whereas controls were maintained 
on water. At the end of the treatment period, all animals received a single oral dose of 
PhIP (5mg/kg). Mutagenic activity was detennined using a strain of Salmonella 
typhimurium YG1024 in the presence of an activation system, containing hepatic S9 
(10%w/v) isolated from Aroclor 1254-induced rats. Results are presented as mean ± SD 
and were corrected for volume of urine excreted. Each analysis was conducted in 
triplicate. *P < 0.001 represents comparison between the groups treated with tea and 
control.
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Discussion 6.4
This study was designed to establish whether a single day (short-term) or one month 
(long-term) intake of Doash tea extract could influence the metabolic pathways of IQ and 
PhIP, as monitored indirectly by the urinary excretion of mutagenicity. S. typhimurium 
bacterial strain (0-acetylase expressing strain YGI024) was employed, in the presence and 
absence of an activation system (Aroclor 1254-induced S9), due to its high sensitivity to IQ 
and PhIP amines. One of the initial aims of this study was to establish the relationship 
between the dosage of IQ or PhIP, administered orally, and urinary mutagenic activity.
The results demonstrated that even a single day or one month intake of Doash tea 
extract, can influence the metabolism of IQ and PhIP, leading to a decrease in the urinary 
excretion of mutagenicity. Unexpectedly, the extent of reduction in the excretion of pro­
mutagens in urine after exposure to Doash extract for only one day, is of the same order as 
that achieved by similar treatment for one month; this reflects the fact that Doash aqueous 
extract active components (terpenes) have a half-life of less than 24 hours.
The heterocyclic amines (IQ and PhIP) are indirect-acting mutagens and carcinogens, 
that require metabolic activation in order to manifest their genotoxicity. Both heterocyclic 
amines are oxidised by microsomal cytochrome P450 enzymes to the corresponding 
hydroxylamine, which is conjugated with acetate or sulphate, to generate the acetoxy or 
sulphatoxy esters that break down spontaneously to release the nitrenum ion, which is 
believed to be the ultimate carcinogen (Kleman. and Overvik. 1995). In accordance with
I  143
the studies of (McArdle et aL, 1999 and Yoxall et aL, 2004) the present results 
demonstrated that exposure to Doash tea, for either one day or one month, suppressed the 
excretion of both direct and indirect acting mutagens in the urine of rats treated with a 
single dose of IQ; this effect appears to be related to a rise in the expression of CYP1A2 in 
the liver.
The potent in vitro and in vivo antimutagenic activity of Doash tea against both 
heterocyclic amines is primarily due to its ability to inhibit their bioactivation by inhibiting 
CYP1A2, the cytochrome P450 enzyme, and catalysing their activation through N- 
hydroxylation (Batttula, et aL, 1967; Aoyama, et aL, 1989).
This study has also shown that green tea (positive control) decreased the urinary 
excretion of both mutagens IQ and PhIP, and this is in agreement with previous studies (Bu 
Abbas aA, 1994).
In summary, the present study revealed that both the short-term and long-term intake 
of Doash tea extract diminishes the excretion of indirect- acting mutagens in rats treated 
with IQ or PhIP; the antimutagenic effect is associated with a decrease of hepatic CYPIA2 
expression as detected with western blot analysis and a phase I enzyme assay 
(déméthylation of methoxyresorufin), which is involved in the metabolism of the 
carcinogens ( IQ and PhIP).
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CHAPTER 7
General Discussion
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Doash {Origanum majorana) is an herbaceous and perennial plant native to Saudi 
Arabia and the Mediterranean, where it is cultivated as a food flavour. Traditionally, it is 
used as a folk remedy to treat a number of diseases (Mossa et ah, 2000). It was 
hypothesised that, in addition to its common uses, Doash (Origanum majorana L.) may 
elicit potential antimutagenic and anticarcinogenic properties.
7.1 Antimutagenic effect of Doash extract
Since Doash extract has already been shown to inhibit the production of free 
radicals (Jun et aL, 2001) and prevent genotoxicity as established in the Ames test in the 
current studies, further studies were undertaken to define the chemical mechanism 
underlying this process. One such explanation for the antimutagenic effect of Doash, is the 
possibility that this herb modulates the enzyme activities that mediate the metabolic 
activation of chemical carcinogens, such as heterocyclic amines, polycyclic aromatic 
hydrocarbons and nitrosamines (Wang et aL, 1988 & 1992; Chung et aL, 1993; Katiyar et 
aL, 1993). It is possible, therefore, that Doash possesses antimutagenic activity by 
inhibation of promutagen and procarcinogen metabolism through inhibition of GYP P450 
subfamily and enzyme activities.
Cytochrome P450 enzymes are the major biotransforming systems responsible for 
the metabolism of many carcinogens. They are believed to be responsible for the 
metabolism of more than 90% of known chemical carcinogens (Rendic & Di Carlo 1997), 
including polycyclic aromatic hydrocarbons, heterocyclic amines and aromatic amines 
(loannides & Lewis 2004). Several dietary phytochemicals have been shown to possess
146
chemopreventive activity by modulating the activities of the enzymes that catalyse the 
metabolic activation, or deactivation, of chemical carcinogens (loannides 1999,2002b).
Doash extracts possess powerful antimutagenic properties, which is supported by 
the study of Qari (2008) who revealed that Origanum majorana has antimutagenic 
potential against sodium azide-induced chromosomal aberrations in Vicia faba root 
meristem cells. In addition, Ghaly et al (2008) found that Zizphus jujuba and O. majorana 
extracts showed protective effects against hydroquinone induced cytogenetic disorders, 
whereas animals treated with extracts alone were comparable to the controls; one possible 
mechanism of action being inhibition of the metabolic activation of chemical carcinogens 
to their reactive metabolites. The health benefits of Doash could be derived from additive 
and synergistic interactions of the various phytochemicals present in Doash leaves. Among 
these chemicals are monoterpenes, such as d-limonene, which is known to inhibit rat 
mammary and other tumour development (Maltzman et al, 1989; Crowell et al, 1994; 
Chen et al, 1999); carotenoids, which possess antioxidant activity (Nishino et al, 2005); 
vitamins, such as vitamin C, which act as a competitive inhibitor of nitrosamine formation 
from nitrate and amides (Fong et al, 1976; Oliveira et al, 2003), and vitamin E (a- 
tocopherol) which acts as a powerful antioxidant with multiple roles (Sung et al, 2002).
7.2 Effect of Doash on phase I enzyme activity
It was noted that the inhibition of bioactivation pathways, catalysed by cytochrome 
P450-dependent metabolism, may be responsible at least in part for the in vitro 
antimutagenic effect of Doash; however, other mechanisms may be involved and should
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therefore be explored. For example, components of Doash may act as scavengers of 
oxidative free radicals formed during xenobiotic and normal endobiotic metabolism. 
Scavenging of reactive oxygen species (ROS), such as the hydroxyl radical, has been 
shown to correlate with the antimutagenic activity of various teas against food-bome 
carcinogens (Yen & Chen 1995), and influence the post-initiation phase of carcinogenesis 
(Waltenberg 1992). For example, the food carcinogen IQ undergoes an activation process 
involving N-hydroxylation, followed by the estérification of hydroxylamine with sulphate 
and acetate to generate sulphatoxy and acetoxy esters, respectively (loannides & Lewis 
2004). The esters break down spontaneously to generate nitrenium ion, the presumed 
ultimate carcinogen. Any factors that disrupt the balance between activation and 
deactivation will eventually alter the delicate balance between the two pathways, and 
consequently, alter the toxicity and carcinogenicity of the challenging chemical (loannides 
& Lewis 2004).
Since the induction of CYPl family is highly associated with the bioactivation of 
many chemical carcinogens (loannides and Parke, 1990; Christou et ah, 1995), it is 
conceivable that Doash may modulate the CYPl-mediated activation of chemical 
carcinogens, as it has been shown to up-regulate CYPl A in vivo in rats. CYP1A2 catalyses 
the bioactivation of major classes of carcinogens, including; aromatic amines, heterocyclic 
amines (Kleman and Overvik 1995), mycotoxins, 4-(methylnitrosamino)-1 -(3-pyridyl)-1 - 
butanone and aminoazobenzenes (loannides & Lewis 2004). Among the heterocyclic 
amines (IQ, PhIP), Doash possesses a potent, anti mutagenic effect, as shown in the Ames 
test. The present study shows that a Doash extract is able to prevent the IQ mutagenic 
effect, which may be explained by its ability to interfere with IQ metabolic activation.
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mediated by CYP1A2 via the A-oxidation reaction (loannides and Parke 1990). 
Methoxyresorufin is a probe used to measure CYP1A2 activity (Namkung et al, 1988). In 
a dose-response fashion, Doash extract showed a strong inhibitory activity toward this 
enzyme.
Similarly, the mutagenic effect of benzo[a]pyrene requires a bioactivation pathway 
mediated by CYPIAI. The 0-deethylation reaction of ethoxyresorufin, mediated by 
CYPlAl (Burke and Mayer 1974), was strongly inhibited by Doash extract, with this 
inhibition being dose dependent. Using 500ul of Doash extract (corresponding to lOmg of 
fresh Doash leaves), the enzyme activity was inhibited by almost 90%.
The associated elevation of cytochrome P450 levels in response to chemical 
carcinogenesis is supported by extensive experimental studies (Steele et al, 1985; Nebert 
1989; Yano et al, 1989; loannides & Parke 1993; Yang 2003), while the inhibition of 
CYPlAl and CYP1A2 by Doash extract suggests a potential chemoprevention against 
carcinogens, which require bioactivation by these isoforms.
The 0-depentylation of pentoxyresorufin is selectively catalysed by CYP2B (Lubet 
et al, 1985; Wang et al, 1992). Unlike the other two dealkylating enzymes, 
(ethoxyresorufin and methoxyresorufin), in vitro study Doash extract significantly 
stimulated CYP2B activity at a low concentration, while increasing the concentration of 
Doash extract above 100 pi, exhibited an inhibitory effect.
The CYP2E sub-family contains one single enzyme in humans and most animal 
species (CYP2E1). Through the catalytic action of this enzyme, it generates reactive 
oxygen species (ROS), which destroy cellular membranes and react with biomolecules,
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such as proteins and nucleic acids. It also has an extensive role in chemical carcinogenesis 
(loannides & Lewis 2004). P-nitrophenol hydroxylase activity is catalyzed by CYP2EI, 
which involves the hydroxylation of p-nitrophenol to nitrocatechol (Koop et ah, 1989).
This isoform is believed to mediate the bioactivation of nitrosoamines, including 
nitrosopyrrolidine, which has been confirmed using cDNA expressed human cytochrome 
P450s (Flammang et aL, 1993). Different concentrations of Doash extract used in this study 
were effective inhibitors of CYP2E1. In fact, the profound reduction of C Y PlA l,
CYP1A2 and CYP2EI isozyme activities by Doash extract resembles several studies 
conducted on green tea by many researchers (Stavric et al, 1964; Bu-Abbas et al, 1994 
&1997; Steele et al, 1985; Wang et al, 1988; Yen & Chen 1996; loannides 1999).
This study also indicates that the inhibitory effect of Doash, on the mutagenesis of 
several dietary-born and environmental genotoxicants, which is apparently due to the 
interference of Doash phytochemicals with the metabolic activation of these mutagens and 
carcinogens. In these aspects, Doash tea has a powerful chemopreventive effect against 
structurally diverse classes of chemical carcinogen. Another possible chemopreventive 
aspect of Doash is through modulation of phase II conjugation reactions. Decreasing the 
availability of a the genotoxic metabolites of chemical catcinogens from the body, by 
forming more water-soluble conjugates, will consequently decrease the chance of an 
interaction with DNA through adduct formation that may lead to cancer; this is supported 
by Ghaly et al (2008) who state that O. majorana extracts contain several chemical 
compounds with proven have antioxidant, anti-tumour and antimutagenic effects, such as 
y terpinene, linalool, a  terpineal, a terpinolene, a terpinene, (3-Caryophllene and 
Spathulenol.
150
7.3 Biological effect of Doash tea fractions
It is desirable to investigate the possible antimutagenic actions of Doash tea 
fractions against different classes of carcinogens. The results obtained indicate that the 
Doash aqueous extract decreased the mutagenicity of IQ, benzo(a) pyrene, 
nitrosopiperidine and MNNG, showing different degrees of inhibition. This variation in 
the inhibitory effect may be related to the amount of active ingredent (terpene) of Doash 
extract or the difference in the antimutagenic potency of active compounds that relates to 
no 4 and 5 fractions of aqueous Doash extract. The activity of aqueous extract present of 
terpene as explaned by Crocoll C et al., 2010.
Faleiro et al., (2005), have reported that O.major ana contains mainly three 
compounds; thymol, y-terpinene and p-cymene. Antioxidant activity of O. majorana 
essential oil (Baratta et al, 1998), and its purified form (Jun et a l, 2001), have been 
reported to represent an alternative for potential treatment and/or prevention of certain 
chronic ailments, like cancer (Arcila-Lozano et al, 2004). The HPLC analysis of Doash 
extract displayed this. Fraction (5) was the most potent inhibitor of mutagenicity of all 
mutagens, except nitrosopiperidine, for which fraction (4) was the most potent. The 
chemical component of Origanum majorana, such as a-terpineol, carvicrol and urosolic 
acid, have a powerful antioxidant activity(Ruberto and Baratta, 2000) as the antimutagenic 
effects of Doash tea fraction (5) or (4) towards IQ are the same. Dealkylation of 
methoxyresorufin was inhibited when Doash extract fractions Nos. (4) & (5) were added.
In the in vivo study, the hepatic xenobiotic-metabolising cytochrome P450 enzyme 
system showed that the administration of Doash extract exerts a significant inhibitory effect
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on methoxyresorufin, ethoxyresorufin, pentoxyresorufin and erythromycin demethylase, 
but only a slight decrease in p-nitrophenol hydroxylase. This is confirmed with 
immunoblot analysis, which revealed that the inhibition of CYP1A2, CY PlA l, CYP2B, 
CYP3A and CYP2E1 respectively. The results obtained demonstrated that the treatment of 
rats with Doash tea extracts (2 % w/v) for four weeks caused a selective decrease in hepatic 
cytochrome P450, such as CYP2B and CYPl A.
It is possible that Doash tea may possess anticarcinogenic potential by directing the 
metabolism of the chemical carcinogens in such a way as to favour their detoxication. 
Therefore, the present study was also undertaken to establish whether the decrease in 
mixed-fiinction oxidase activities and carcinogen activation is accompanied by similar 
changes in the phase II enzyme systems. In this respect, glutathione conjugation is 
probably the most effective metabolic pathway for eliminating reactive intermediates, a 
process catalysed by glutathione S-transferase. Such mechanism of action, however, 
appeared unlikely since the activity of glutathione S-transferase measured using CDNB and 
DCNB as substrates, was unaffected by the treatment with Doash extracts. The same 
treatment with Doash also failed to modulate sulphotransferase and microsomal epoxide 
hydrolase activities in rat liver. Similarly, pre-treatment of rats with Doash tea extract did 
not show any observable increase in glucuronidation.
7.4 Effect of Doash on urinary mutagenicity in rats exposed to heterocyclic
amines
More studies employed in the S. typhimurium bacterial strain 0-acetylase, expressing 
strain YG1024, in the presence and absence of an activation system (Aroclor 1254-induced
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S9) in the Ames test, were conducted to evaluate the effect of Doash exposure on the 
carcinogen activation. The aim of these studies was to establish whether an oral intake of 
Doash tea extract for 1 day (short term) or 4 weeks (long term) could influence the 
metabolic pathways of IQ or PhIP, as monitored indirectly by the urinary excretion of 
mutagens. The results demonstrated that an intake of Doash tea extract (2g % w/v) for 
even a single day, or 4 weeks, can influence the metabolism of IQ or PhIP, leading to a 
decrease in the urinary excretion of mutagens. However, unexpected data was observed 
that the extent of reduction in the excretion of pro-mutagens in urine after exposure to 
Doash extract for I day was the same as that achieved by a similar treatment of 4 weeks. 
The results suggest that exposure to Doash tea extract for either one day, or four weeks, 
suppressed the excretion of both carcinogens (IQ and PhIP) in the urine of rats treated with 
a single dose of carcinogen.
The potent in vitro antimutagenic activity of Doash tea, against both heterocyclic 
amines investigated in the current study, were primarily due to its ability to inhibit their 
bioactivation by inhibiting CYP1A2, the cytochrome P450 enzyme, catalyzing their 
activation through N-hydroxylation as mentioned by Battula, et al, 1987; and Aoyama, et 
a/., (1989).
Based on these records, it appears that, in vivo, Doash tea aqueous extract can affect 
the mutagenicity of various structurally diverse promutagens employed in the study, 
including food-bome carcinogen, by decreasing cytochrome P450-mediated activation. On 
the other hand, these in vivo mechanisms were also operative in vitro, as discussed before.
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In conclusion, the present study has found that even short-term exposure to Doash 
tea extract is capable of influencing the metabolic fate of IQ or PhIP and this is most likely 
related to CYP1A2 inhibition.
Future research
Due to insufficient data on Doash extract, or its active components at the molecular 
level, more studies will be needed in this field.
1- To determine the active components of Doash leaves, including 
macronutrients, micronutrients and other bioactive, phytochemical 
ingredients, which wil be test as a replacable therapy in medicinal folk.
2- Studying the antioxidant, anticarcinogen activities of Doash fractions.
3- To investigate the mechanism of action of fractions at molecular level 
( up-regulation or down-regulation of CYP expression gene).
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Abstract
Origanum majorana L (Doash) is one of the traditional remedy that is used as a tea and to 
treat ailments, in the Kingdom of Saudi Arabia. The present study has attempted to 
evaluate the inhibitory action of Doash fractions on the bioactivation of selected food 
mutagens and direct-acting mutagens. Four Sallmonella bacterial strains (TA98, TA97, 
TA 100 and TA1530) were used in the present study. These strains contain different 
mutations in the histidine operon, allowing the bacteria to detect different types of 
mutation. The two strains (TA98 and TA97) are capable of detecting frameshift mutations, 
while TAIOO and TA1530 are able to detect base-pair substitutions. The liver homogenate 
and other subcellular fractions were prepared. Identification of Doash fractions was 
conducted using the high-performance liquid chromatography/mass spectrometry system. 
The results of the present study demonstrated that the Doash tea fraction components have 
the ability to reduce the in vitro mutagencity of several promutagens, which were employed 
in this study. Fraction No. 5 (with the highest content of solid) was the most potent 
inhibitor of the mutagenicity of all promutagens employed in this study. The antimutagenic
176
effect of Doash tea extract, and its various fractions, was pronounced, indicating that the 
metabolism of cytochrome P450 1A2 isozyme is likely to be inhibited.
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Abstract
Human carcinogens are formed mainly due to the lifestyle and diet that is followed. It is 
well known that dietary factors play a crucial role in the aetiology of human cancer. The 
new attractions of drug discovery using natural products remain an important issue in the 
current herbal medicine research. The present study aimed to evaluate the antimutagenic 
activity of the water extracts of Doash leaves against several known mutagens, both direct- 
and indirect-acting, belonging to different chemical classes. These classes are heterocyclic 
amines (HAs), polycyclic aromatic hydrocarbons and nitrosamines. The antimutagenic 
activity will be determined in Salmonella/microsomal system (Ames) using strains of 
Salmonella Typhimurium. Four Salmonella bacterial strains (TA98, TA97, TAIOO and 
TA1530) were used in the present study. Results obtained showed that Doash extract 
possesses powerful antimutagenic properties, which impair the deleterious effects of 
various chemicals used in this study. One possible mechanism involved in this protection is 
the inhibition of the metabolic activation of chemical carcinogens to their reactive 
metabolites. We also suggest that the health benefits of Doash could be derived from the 
additive and synergistic combinations of the various phytochemicals present in Doash 
leaves. Other studies should also be conducted to determine the active components of 
Doash leaves, including macronutrients, micronutrients and other phytochemicals. Clinical 
studies should be performed before any claims that Doash consumption offers 
chemoprotection against cancer can be made.
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